<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Exercise‐based rehabilitation programmes for pulmonary hypertension - Morris, NR - 2023 | Cochrane Library</title> <meta content="Exercise‐based rehabilitation programmes for pulmonary hypertension - Morris, NR - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011285.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Exercise‐based rehabilitation programmes for pulmonary hypertension - Morris, NR - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011285.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011285.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Exercise‐based rehabilitation programmes for pulmonary hypertension" name="citation_title"/> <meta content="Norman R Morris" name="citation_author"/> <meta content="n.morris@griffith.edu.au" name="citation_author_email"/> <meta content="Fiona D Kermeen" name="citation_author"/> <meta content="The Prince Charles Hospital" name="citation_author_institution"/> <meta content="Arwel W Jones" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Joanna YT Lee" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Anne E Holland" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD011285.pub3" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/03/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011285.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011285.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011285.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Exercise; Exercise Therapy [adverse effects]; *Hypertension, Pulmonary; Quality of Life" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011285.pub3&amp;doi=10.1002/14651858.CD011285.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="tlnpj831";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011285\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011285\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","pt","ms","hr","fr","hu","zh_HANT","th","ja","fa","id","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011285.pub3",title:"Exercise\\u2010based rehabilitation programmes for pulmonary hypertension",firstPublishedDate:"Mar 22, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tlnpj831&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011285.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011285.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011285.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011285.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011285.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011285.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati telaah sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011285.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011285.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011285.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011285.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7342 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011285.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/appendices#CD011285-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/supinfo/CD011285StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/supinfo/CD011285StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Exercise‐based rehabilitation programmes for pulmonary hypertension</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#CD011285-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Norman R Morris</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#CD011285-cr-0005">Fiona D Kermeen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#CD011285-cr-0006">Arwel W Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#CD011285-cr-0007">Joanna YT Lee</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information#CD011285-cr-0008">Anne E Holland</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information/en#CD011285-sec-0091">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 March 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011285.pub3">https://doi.org/10.1002/14651858.CD011285.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011285-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011285-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011285-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011285-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011285-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011285-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011285-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD011285-abs-0017">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011285-abs-0001" lang="en"> <section id="CD011285-sec-0001"> <h3 class="title" id="CD011285-sec-0001">Background</h3> <p>Individuals with pulmonary hypertension (PH) have reduced exercise capacity and quality of life. Despite initial concerns that exercise training may worsen symptoms in this group, several studies have reported improvements in functional capacity and well‐being following exercise‐based rehabilitation. </p> </section> <section id="CD011285-sec-0002"> <h3 class="title" id="CD011285-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of exercise‐based rehabilitation for people with PH compared with usual care or no exercise‐based rehabilitation. </p> </section> <section id="CD011285-sec-0003"> <h3 class="title" id="CD011285-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 28 June 2022. </p> </section> <section id="CD011285-sec-0004"> <h3 class="title" id="CD011285-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) in people with PH comparing supervised exercise‐based rehabilitation programmes with usual care or no exercise‐based rehabilitation. </p> </section> <section id="CD011285-sec-0005"> <h3 class="title" id="CD011285-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were 1. exercise capacity, 2. serious adverse events during the intervention period and 3. health‐related quality of life (HRQoL). Our secondary outcomes were 4. cardiopulmonary haemodynamics, 5. Functional Class, 6. clinical worsening during follow‐up, 7. mortality and 8. changes in B‐type natriuretic peptide. We used GRADE to assess certainty of evidence. </p> </section> <section id="CD011285-sec-0006"> <h3 class="title" id="CD011285-sec-0006">Main results</h3> <p>We included eight new studies in the current review, which now includes 14 RCTs. We extracted data from 11 studies. The studies had low‐ to moderate‐certainty evidence with evidence downgraded due to inconsistencies in the data and performance bias. The total number of participants in meta‐analyses comparing exercise‐based rehabilitation to control groups was 462. The mean age of the participants in the 14 RCTs ranged from 35 to 68 years. Most participants were women and classified as Group I pulmonary arterial hypertension (PAH). Study durations ranged from 3 to 25 weeks. Exercise‐based programmes included both inpatient‐ and outpatient‐based rehabilitation that incorporated both upper and lower limb exercise. </p> <p>The mean six‐minute walk distance following exercise‐based rehabilitation was 48.52 metres higher than control (95% confidence interval (CI) 33.42 to 63.62; I² = 72%; 11 studies, 418 participants; low‐certainty evidence), the mean peak oxygen uptake was 2.07 mL/kg/min higher than control (95% CI 1.57 to 2.57; I² = 67%; 7 studies, 314 participants; low‐certainty evidence) and the mean peak power was 9.69 W higher than control (95% CI 5.52 to 13.85; I² = 71%; 5 studies, 226 participants; low‐certainty evidence). Three studies reported five serious adverse events; however, exercise‐based rehabilitation was not associated with an increased risk of serious adverse event (risk difference 0, 95% CI −0.03 to 0.03; I² = 0%; 11 studies, 439 participants; moderate‐certainty evidence). The mean change in HRQoL for the 36‐item Short Form (SF‐36) Physical Component Score was 3.98 points higher (95% CI 1.89 to 6.07; I² = 38%; 5 studies, 187 participants; moderate‐certainty evidence) and for the SF‐36 Mental Component Score was 3.60 points higher (95% CI 1.21 to 5.98 points; I² = 0%; 5 RCTs, 186 participants; moderate‐certainty evidence). There were similar effects in the subgroup analyses for participants with Group 1 PH versus studies of groups with mixed PH. Two studies reported mean reduction in mean pulmonary arterial pressure following exercise‐based rehabilitation (mean reduction: 9.29 mmHg, 95% CI −12.96 to −5.61; I² = 0%; 2 studies, 133 participants; low‐certainty evidence). </p> </section> <section id="CD011285-sec-0007"> <h3 class="title" id="CD011285-sec-0007">Authors' conclusions</h3> <p>In people with PH, supervised exercise‐based rehabilitation may result in a large increase in exercise capacity. Changes in exercise capacity remain heterogeneous and cannot be explained by subgroup analysis. It is likely that exercise‐based rehabilitation increases HRQoL and is probably not associated with an increased risk of a serious adverse events. Exercise training may result in a large reduction in mean pulmonary arterial pressure. Overall, we assessed the certainty of the evidence to be low for exercise capacity and mean pulmonary arterial pressure, and moderate for HRQoL and adverse events. Future RCTs are needed to inform the application of exercise‐based rehabilitation across the spectrum of people with PH, including those with chronic thromboembolic PH, PH with left‐sided heart disease and those with more severe disease. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011285-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011285-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011285-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011285-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011285-abs-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011285-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011285-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/hu#CD011285-abs-0013">Magyar</a> </li> <li class="section-language"> <a class="" href="full/id#CD011285-abs-0022">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011285-abs-0019">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011285-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011285-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011285-abs-0023">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD011285-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011285-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD011285-abs-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011285-abs-0016">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011285-abs-0002" lang="en"> <h3>Exercise‐based rehabilitation in pulmonary hypertension</h3> <p><b>Key messages</b> </p> <p>In people with pulmonary hypertension who are medically stable, exercise‐based rehabilitation is most likely to be safe and improve quality of life. The evidence suggests that exercise‐based rehabilitation may result in a large increase in exercise capacity and a reduction in mean pulmonary arterial pressure. </p> <p><b>What is pulmonary hypertension?</b> </p> <p>Pulmonary hypertension is a condition in which the blood pressure in the arteries that carry blood from the heart to the lungs is elevated well above normal. Often with a gradual onset, it affects people of all ages, reduces their quality of life and results in premature death. Exercise‐based rehabilitation is recommended for other chronic lung and heart disease populations; however up until recently, exercise was not recommended for pulmonary hypertension. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to review the evidence from well‐designed clinical trials that compared exercise‐based rehabilitation with usual care. </p> <p><b>What did we do?</b> </p> <p>We searched medical databases for clinical trials comparing exercise training versus usual care in people with PH to see if exercise improved short‐ and long‐term outcomes such as exercise capacity, health‐related quality of life, serious side effects and changes in the pressure in the pulmonary circulation. The updated review included 14 studies with 574 people, and we included data from 11 studies in analyses (462 participants). </p> <p><b>What did we find?</b> </p> <p>The studies reported that exercise‐based rehabilitation may result in large increases in exercise capacity as evaluated by how far people could walk in six minutes and maximal oxygen consumption using a specialised exercise test; however, there was marked variability in this response. Health‐related quality of life was also most likely to be improved and exercise‐based rehabilitation may also result in a large reduction in the pressure in the pulmonary circulation. Serious side effects were rare and exercise‐based rehabilitation was unlikely to increase the risk of them. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>The evidence from these trials was of low to moderate quality. The main limitations in the studies was a lack of allocation concealment (participants knew whether they were in the exercise group or not, which could cause bias) and studies did not report the results of all the outcome data. In addition, some outcomes, for example exercise capacity, had a variable response, which we could not explain by examining different subgroups of people. </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is current to 28 June 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011285-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011285-sec-0074"></div> <h3 class="title" id="CD011285-sec-0075">Implications for practice</h3> <section id="CD011285-sec-0075"> <p>The results of this updated review suggest that supervised exercise‐based rehabilitation in people with pulmonary hypertension (PH) who are stable on medical therapy may lead to large improvements in exercise capacity, which for the 6MWD exceeded the minimal important difference. The conclusions are based on low‐certainty evidence with marked heterogeneity in the results that was not explained by subgroup analyses. There is moderate‐certainty evidence that exercise‐based rehabilitation is safe, with few adverse events reported. Moderate‐certainty evidence suggests that exercise‐based rehabilitation likely results in an increase in health‐related quality of life. The low‐certainty evidence for the change in pulmonary haemodynamics suggest that exercise‐based rehabilitation may result in large decreases in mean pulmonary arterial pressure. The results of this review apply primarily to people with moderate severity PH (New York Heart Association (NYHA)/World Health Organization (WHO) Functional Class II and III); the impact of rehabilitation in more severe PH (Class IV) is unknown. The duration of benefits for exercise‐based rehabilitation in PH remain unknown. </p> </section> <h3 class="title" id="CD011285-sec-0076">Implications for research</h3> <section id="CD011285-sec-0076"> <p>Given the inconsistency of results of studies to date, particularly for changes in exercise capacity, future randomised controlled trials are needed to inform the application of exercise‐based rehabilitation across the spectrum of people with PH, including diagnostic subgroups such as chronic thromboembolic PH (WHO Group 4), PH with left‐sided heart disease (WHO Group 2) and those with more severe disease. It is essential that future trials provide clarity around participant selection in a CONSORT diagram, so that it is clear to which population the results can be applied. Additional studies are required to determine the optimal exercise training strategy for people with PH, including modality and intensity of training, length of programme, degree of supervision and the optimal setting for delivery of exercise training (e.g. inpatient versus outpatient). Longer‐term studies are required to assess the durability of benefits, and to determine the effect of exercise rehabilitation on critical outcomes such as time to clinical worsening and survival. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011285-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011285-sec-0008"></div> <div class="table" id="CD011285-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Exercise compared to control for pulmonary hypertension</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise compared to control for pulmonary hypertension</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with pulmonary hypertension </p> <p><b>Settings:</b> inpatient or outpatient rehabilitation, or both </p> <p><b>Intervention:</b> exercise training </p> <p><b>Comparison:</b> control: people who had usual care and did not undertake exercise training programme </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Exercise</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity: 6MWD</b><br/>Distance, metres<br/>Follow‐up median 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in 6MWD ranged from −29 m to 16.9 m</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in 6MWD in the intervention groups was <b>48.52 m higher</b> (33.42 to 63.62 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>418<br/>(11 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may result in a large increase in 6MWD.</p> <p>PAH subgroup (3 studies, 71 participants): mean 6MWD for intervention group was <b>63.97 m</b> higher (95% CI 8.74 to 119.21 higher; P = 0.02, I² = 75%). </p> <p>Mixed PH subgroup (8 studies, 347 participants): mean 6MWD for intervention group was <b>44.16 m</b> higher (95% CI 28.97 to 59.36 higher; P &lt; 0.001, I² = 72%). </p> <p>Examining heterogeneity, inpatient vs outpatient exercise training: included inpatient exercise training (5 studies, 280 participants): mean 6MWD for intervention group was <b>50.54 m</b> higher (95% CI 39.00 to 62.07 higher; P &lt; 0.001, I² = 81%). Outpatient exercise training (6 studies, 138 participants): mean 6MWD for intervention group was <b>36.69 m</b> higher (95% CI 27.85 to 45.52 higher; P &lt; 0.001, I² = 53%). </p> <p>Minimal important difference was 30 m.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity: VO<sub>2peak</sub> </b> </p> <p>Oxygen uptake, mL/kg/min<br/>Follow‐up median 13.5 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in VO<sub>2peak</sub> ranged from −0.5 mL/kg/min to 0.4 mL/kg/min </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean VO<sub>2peak</sub> in the intervention groups was <b>2.07 mL/kg/min higher</b><br/>(1.57 to 2.57 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>314<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may increase peak oxygen uptake.</p> <p>PAH subgroup (2 studies, 36 participants): mean VO<sub>2peak</sub> in the intervention groups was <b>1.28 mL/kg/min higher</b> (95% CI 0.19 lower to 2.75 higher; P = 0.09, I² = 0%). </p> <p>Mixed PH subgroup (5 studies, 278 participants): mean VO<sub>2peak</sub> in the intervention groups was <b>2.17 mL/kg/min higher</b> (95% CI 1.64 to 2.70 higher, P &lt; 0.001, I² = 72%). </p> <p>Examining heterogeneity, inpatient vs outpatient exercise training: included inpatient exercise training (3 studies, 217 participants): mean VO<sub>2peak</sub> for intervention group was <b>2.00</b> <b>mL/kg/min higher</b> (95% CI 1.36 to 2.64 higher, P &lt; 0.001, I² = 83%). Outpatient exercise training (4 studies, 97 participants): mean VO<sub>2peak</sub> for intervention group was <b>2.18 mL/kg/min higher</b> (95% CI 1.38 to 2.98 higher, P &lt; 0.001, I² = 21%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity: peak power</b> </p> <p>watts<br/>Follow‐up median 13.5 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in W<sub>peak</sub> ranged from −4 W to 10 W </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean exercise capacity: peak power in the intervention groups was <b>9.69 W higher</b><br/>(5.52 to 13.85 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may increase peak power.</p> <p>PAH subgroup (2 studies, 36 participants): mean peak power in the intervention groups was <b>14.24 W higher</b> (95% CI 5.78 to 22.70 higher; P &lt; 0.001, I² = 0%). </p> <p>Mixed PH subgroup (3 studies, 190 participants): mean W<sub>peak</sub> in the intervention groups was <b>8.22 W higher</b> (95% CI 3.43 to 13.01 higher; P &lt; 0.001, I² = 84%). </p> <p>Examining heterogeneity, inpatient vs outpatient exercise training: included inpatient exercise training (3 studies, 190 participants): mean peak power in the intervention groups was <b>8.22 W higher</b> (95% CI 3.43 to 13.01 higher; P = 0.008, I² = 84%). Outpatient exercise training only (2 studies, 36 participants): mean peak power in the intervention groups was <b>14.24 W higher</b> (95% CI 5.78 to 22.70 higher; P &lt; 0.001, I² = 0%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> <p>Follow‐up median 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 total for control group</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RD 0 (–0.03 to<br/>0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>439 (11 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training is probably not associated with an increased risk of a serious adverse event. </p> <p>PAH subgroup (3 studies, 109 participants): RD –0.01 (95% CI –0.07 to 0.06). 1 death reported in the control group (<a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). Mixed PH subgroup (8 studies, 330 participants): RD 0.01 (95% CI –0.03 to 0.04). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQoL SF‐36: PCS</b> </p> <p>units</p> <p>Follow‐up median 11 weeks. Note higher scores = better health status</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the PCS ranged from ‐1 to 3.9 points</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean HRQoL SF‐36: PCS in the intervention groups was <b>3.98 points higher</b> (1.89 to 6.07 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training likely improves the physical components of HRQoL.</p> <p>PAH subgroup (2 studies, 33 participants): mean HRQoL SF‐36: PCS in the intervention groups was <b>4.63 higher</b> (95% CI 0.80 to 8.47 higher). </p> <p>Mixed PH subgroup (3 studies, 33 participants): mean HRQoL SF‐36: PCS in the intervention groups was <b>3.71 higher</b> (95% CI 1.20 to 6.19 higher). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQoL SF‐36: MCS</b> </p> <p>units</p> <p>Follow‐up median 11 weeks. Note higher scores = better health status</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the MCS ranged from −3.1 to 2.3 points.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean HRQoL SF‐36: MCS in the intervention groups was <b>3.60 points higher</b> (1.21 to 5.98 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training likely improves the mental components of HRQoL.</p> <p>PAH subgroup (2 studies, 33 participants): mean HRQoL SF‐36: MCS in the intervention groups was <b>4.17 points higher</b> (95% CI 0.01 to 8.34 higher). </p> <p>Mixed PH subgroup (3 studies, 153 participants): mean HRQoL SF‐36: MCS in the intervention groups was <b>3.31 points higher</b> (95% CI 0.40 to 6.22 higher). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiopulmonary haemodynamics (mPAP)</b> </p> <p>mmHg</p> <p>Follow‐up median 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the mPAP ranged from 5 to 5.8 mmHg.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mPAP in the exercise group was <b>9.29 mmHg lower</b> (12.96 to 5.61 mmHg lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>133 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may result in a large decrease in mPAP.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the response on control is the median control group response across studies. </p> <p><b>6MWD:</b> 6‐minute walk distance; <b>CI:</b> confidence interval; <b>HRQoL:</b> health‐related quality of life; <b>MCS:</b> Mental Component Summary; <b>MD:</b> mean difference; <b>mPAP:</b> mean pulmonary arterial pressure; <b>PAH:</b> pulmonary arterial hypertension; <b>PCS:</b> Physical Component Summary; <b>PH:</b> pulmonary hypertension; <b>RD:</b> risk difference; <b>SF‐36:</b> 36‐item Short Form; <b>VO<sub>2peak</sub>:</b> peak oxygen capacity; <b>W:</b> watts. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Five of 11 studies reported incomplete outcome data. Downgraded one level.<br/><sup>b</sup> Inconsistency: I² &gt; 60%. Downgraded one level.<br/><sup>c</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Three of seven studies reported incomplete outcome data. Downgraded one level.<br/><sup>d</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Three of five studies reported incomplete outcome data. Downgraded one level.<br/><sup>e</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Downgraded one level.<br/><sup>f</sup> Both studies had high risk of performance bias (participants and personnel not blinded), high risk of attrition bias and high risk of reporting bias. Downgraded two levels. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011285-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011285-sec-0009"></div> <section id="CD011285-sec-0010"> <h3 class="title" id="CD011285-sec-0010">Description of the condition</h3> <p>Pulmonary hypertension (PH) is a progressive vasculopathy characterised by extensive remodelling of the pulmonary vasculature resulting in a narrowing of the arterial lumen (<a href="./references#CD011285-bbs2-0074" title="CasserlyB , KlingerJR . Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Design, Development and Therapy2009;3:269-87.">Casserly 2009</a>). There is a marked increase in pulmonary vascular resistance resulting in right ventricular remodelling and eventual failure, which, in most cases, results in patient death (<a href="./references#CD011285-bbs2-0115" title="TuderRM , ArcherSL , DorfmüllerP , ErzurumSC , GuignabertC , MichelakisE , et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. Journal of the American College of Cardiology2013;62(25 Suppl):D4-12.">Tuder 2013</a>). Confirmatory diagnosis of PH is made via right heart catheterisation in which the patient has a resting mean pulmonary arterial pressure (mPAP) greater than 25 mmHg (<a href="./references#CD011285-bbs2-0083" title="GalièN , HumbertM , VachieryJL , GibbsS , LangI , TorbickiA . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Respiratory Journal2015;46(4):903-75.">Galie 2015</a>). In 2019, the World Symposium on Pulmonary Hypertension recommended lowering the diagnostic mPAP for PH to 20 mmHg (<a href="./references#CD011285-bbs2-0112" title="SimonneauG , MontaniD , CelermajerDS , Denton CP Gatzoulis MA, KrowkaM , et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal2019;53:1801913.">Simonneau 2019</a>); however, this has yet to obtain universal acceptance. PH may arise in association with a broad range of disease states (over 40) of both known and unknown cause. International guidelines classified PH into the following five clinical groups (<a href="./references#CD011285-bbs2-0112" title="SimonneauG , MontaniD , CelermajerDS , Denton CP Gatzoulis MA, KrowkaM , et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal2019;53:1801913.">Simonneau 2019</a>). </p> <p> <ul id="CD011285-list-0001"> <li> <p>Group 1: pulmonary arterial hypertension (PAH)</p> </li> <li> <p>Group 2: PH due to left heart disease</p> </li> <li> <p>Group 3: PH due to lung diseases or hypoxia, or both</p> </li> <li> <p>Group 4: chronic thromboembolic PH (CTEPH)</p> </li> <li> <p>Group 5: PH with unclear multifactorial mechanisms</p> </li> </ul> </p> <p>The incidence of PH varies markedly between the five clinical groups (<a href="./references#CD011285-bbs2-0114" title="StrangeG , PlayfordD , StewartS , DeagueJA , NelsonH , KentA , et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart2012;98(24):1805-11.">Strange 2012</a>)<i>.</i> In one observational cohort study of over 10,000 participants from Armadale and the surrounding region in Western Australia, <a href="./references#CD011285-bbs2-0114" title="StrangeG , PlayfordD , StewartS , DeagueJA , NelsonH , KentA , et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart2012;98(24):1805-11.">Strange 2012</a> reported the minimum indicative prevalence for all groups of PH was 326/100,000, with left heart disease associated with Group 2 being most prevalent. A more‐recent population‐based study of 50,529 people with PH from Ontario, Canada, collected between 1993 and 2012, also reported that Group 2 was the most prevalent and that yearly prevalence rates increased across the duration of the study (<a href="./references#CD011285-bbs2-0119" title="WijeratneDT , LajkoszK , BroglySB , LougheedMD , JiangL , HousinA , et al. Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circulation2018;11(2):e003973.">Wijeratne 2018</a>). Looking at the global impact of PH, Hoeper and colleagues note that the prevalence of PH is 1% of the global population, with prevalence rising to around 10% in people aged older than 65 years (<a href="./references#CD011285-bbs2-0090" title="HoeperMM , HumbertM , SouzaR , IdreesM , KawutSM , Sliwa-HahnleK , et al. A global view of pulmonary hypertension. Lancet Respiratory Medicine2016;4(4):306-22.">Hoeper 2016</a>). </p> <p>Regardless of aetiology, PH is characterised by limited exercise capacity and a progressive increase in breathlessness. Historically treatment options for PH were limited and patient prognosis poor. One early National Institutes of Health (NIH) Registry (published in the early 1980s), which included idiopathic, congenital and drug‐induced PAH, reported a one‐year survival rate of only 68% and three‐year survival rate of only 48% (<a href="./references#CD011285-bbs2-0108" title="RichS , DantzkerDR , AyresSM , BergofskyEH , BrundageBH , DetreKM , et al. Primary pulmonary hypertension: a national prospective study. Annals of Internal Medicine1987;107(2):216-23.">Rich 1987</a>). The development of PH‐specific drug therapies, targeted at the pulmonary vasculature, has significantly improved prognosis. More‐recent registry data (2000 to 2014) reported improved survival rates of over 90% at one year and 73% to 77% at three years (<a href="./references#CD011285-bbs2-0106" title="RådegranG , KjellströmB , EkmehagB , LarsenF , RundqvistB , BlomquistSB , et al. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000–2014. Scandinavian Cardiovascular Journal2016;50(4):243-50.">Radegran 2016</a>). </p> <p>Advances in PH‐specific therapies have improved survival and slowed disease progression. As a result, other treatment options aimed at improving outcomes such as exercise capacity and quality of life have been explored. In people with other chronic heart and lung diseases, there is strong evidence that exercise training improves functional capacity, quality of life and even long‐term survival (<a href="./references#CD011285-bbs2-0113" title="SpruitMA , SinghSJ , GarveyC , ZuWallackR , NiciL , RochesterC , et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine2013;188(8):e13-64.">Spruit 2013</a>). However, until very recently, exercise rehabilitation has been actively discouraged in people with PH for fear it would worsen symptoms and negatively impact on cardiac function (<a href="./references#CD011285-bbs2-0082" title="GalieN , CorrisPA , FrostA , GirgisRE , GrantonJ , JingZC , et al. Updated treatment algorithm of pulmonary arterial hypertension. Journal of the American College of Cardiology2013;62(25 Suppl):60-72.">Galie 2013</a>). One more‐recent statement by the European Respiratory Society on exercise training in PH has noted improvements in exercise capacity, muscular function, quality of life and potentially right ventricular function (<a href="./references#CD011285-bbs2-0086" title="GrünigE , EichstaedtC , BarberàJA , BenjaminN , BlancoI , BossoneE , et al. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. European Respiratory Journal2019;53(2):1800332. [DOI: 10.1183/13993003.00332-2018]">Grunig 2019a</a>); however, gaps in the knowledge exist including an understanding of the optimal training dose, characteristics of supervision, mechanisms of adaptation and the impact of exercise training on long‐term survival (<a href="./references#CD011285-bbs2-0082" title="GalieN , CorrisPA , FrostA , GirgisRE , GrantonJ , JingZC , et al. Updated treatment algorithm of pulmonary arterial hypertension. Journal of the American College of Cardiology2013;62(25 Suppl):60-72.">Galie 2013</a>). </p> </section> <section id="CD011285-sec-0011"> <h3 class="title" id="CD011285-sec-0011">Description of the intervention</h3> <p>Exercise‐based rehabilitation programmes including aerobic and strength training elements are designed to improve both aerobic capacity and muscle strength. Aerobic training involves the activation of a large skeletal muscle mass through an extended period of cycling or walking exercise that is between 20 and 40 minutes in duration. Strength training programmes involve upper and lower body muscle groups with the participant completing a number of sets of exercises at a fixed percentage of a one‐repetition maximum (RM) (<a href="./references#CD011285-bbs2-0113" title="SpruitMA , SinghSJ , GarveyC , ZuWallackR , NiciL , RochesterC , et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine2013;188(8):e13-64.">Spruit 2013</a>). Several different approaches to exercise training have been employed. Supervised programmes may be offered in an outpatient, inpatient or remote setting, involving two to three sessions per week typically over at least a four‐week period. Training approaches vary in intensity, including moderate‐intensity continuous training to high‐intensity interval training. </p> </section> <section id="CD011285-sec-0012"> <h3 class="title" id="CD011285-sec-0012">How the intervention might work</h3> <p>In healthy young and older patients, exercise training results in improved oxygen transport and uptake at peak exercise through both central and peripheral adaptations. Central adaptations include an increase in maximal cardiac output, through an increase in stroke volume (<a href="./references#CD011285-bbs2-0099" title="OgawaT , SpinaRJ , Martin WH 3rd, KohrtWM , SchechtmanKB , HolloszyJO , et al. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation1992;86(2):494-503.">Ogawa 1992</a>). Central adaptations are the result of volume overload‐mediated cardiac remodelling that leads to improved cardiac function at rest and during exercise (<a href="./references#CD011285-bbs2-0099" title="OgawaT , SpinaRJ , Martin WH 3rd, KohrtWM , SchechtmanKB , HolloszyJO , et al. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation1992;86(2):494-503.">Ogawa 1992</a>; <a href="./references#CD011285-bbs2-0103" title="PluimBM , ZwindermanAH , van derLaarseA , van derWallEE . The athlete's heart. A meta-analysis of cardiac structure and function. Circulation2000;101(3):336-44.">Pluim 2000</a>). In the periphery, greater skeletal muscle oxidative capacity occurs with an increase in enzymes associated with cellular respiration, in particular those involved in the citric acid cycle (the Krebs cycle) and oxidative phosphorylation (<a href="./references#CD011285-bbs2-0075" title="CogganAR , SpinaRJ , KingDS , RogersMA , BrownM , NemethPM , et al. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. Journal of Applied Physiology1992;72(5):1780-6.">Coggan 1992</a>; <a href="./references#CD011285-bbs2-0084" title="GollnickPD , ArmstrongRB , SaltinB , SaubertCW , SembrowichWL , ShepherdRE . Effect of training on enzyme activity and fiber composition of human skeletal muscle. Journal of Applied Physiology1973;34(1):107-11.">Gollnick 1973</a>). In addition, there is an increase in the capillary density per myofibril (<a href="./references#CD011285-bbs2-0075" title="CogganAR , SpinaRJ , KingDS , RogersMA , BrownM , NemethPM , et al. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. Journal of Applied Physiology1992;72(5):1780-6.">Coggan 1992</a>; <a href="./references#CD011285-bbs2-0084" title="GollnickPD , ArmstrongRB , SaltinB , SaubertCW , SembrowichWL , ShepherdRE . Effect of training on enzyme activity and fiber composition of human skeletal muscle. Journal of Applied Physiology1973;34(1):107-11.">Gollnick 1973</a>). As a result of these central and peripheral adaptations, there is an increased delivery of oxygen to the exercising myofibril, and an increased capacity to metabolise oxygen for the production of adenosine triphosphate. Transition between myofibril types typically occurs with an increase in the fast twitch oxidative and a decrease in fast twitch glycolytic fibres following exercise training (<a href="./references#CD011285-bbs2-0075" title="CogganAR , SpinaRJ , KingDS , RogersMA , BrownM , NemethPM , et al. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. Journal of Applied Physiology1992;72(5):1780-6.">Coggan 1992</a>; <a href="./references#CD011285-bbs2-0079" title="EnnionS , Sant'ana PereiraJ , SargeantAJ , YoungA , GoldspinkG . Characterization of human skeletal muscle fibres according to the myosin heavy chains they express. Journal of Muscle Research and Cell Motility1995;16(1):35-43.">Ennion 1995</a>; <a href="./references#CD011285-bbs2-0084" title="GollnickPD , ArmstrongRB , SaltinB , SaubertCW , SembrowichWL , ShepherdRE . Effect of training on enzyme activity and fiber composition of human skeletal muscle. Journal of Applied Physiology1973;34(1):107-11.">Gollnick 1973</a>). Moreover, there is an increase in the cross‐sectional area of slow twitch (Type I) and Type IIa fibres in trained individuals (<a href="./references#CD011285-bbs2-0075" title="CogganAR , SpinaRJ , KingDS , RogersMA , BrownM , NemethPM , et al. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. Journal of Applied Physiology1992;72(5):1780-6.">Coggan 1992</a>; <a href="./references#CD011285-bbs2-0084" title="GollnickPD , ArmstrongRB , SaltinB , SaubertCW , SembrowichWL , ShepherdRE . Effect of training on enzyme activity and fiber composition of human skeletal muscle. Journal of Applied Physiology1973;34(1):107-11.">Gollnick 1973</a>). </p> <p>In PH, the factors that contribute to exercise limitation are complex (<a href="./references#CD011285-bbs2-0072" title="BabuAS , ArenaR , MyersJ , PadmakumarR , MaiyaAG , CahalinLP , et al. Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications. Expert Review of Respiratory Medicine2016;10(9):979-90.">Babu 2016b</a>; <a href="./references#CD011285-bbs2-0080" title="FowlerRM , GainKR , GabbayE . Exercise intolerance in pulmonary arterial hypertension. Pulmonary Medicine2012;10:359204. [DOI: 10.1155/2012/359204]">Fowler 2012</a>; <a href="./references#CD011285-bbs2-0100" title="PanagiotouM , PeacockAJ , JohnsonMK . Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?Pulmonary Circulation2015;5(3):424-34.">Panagiotou 2015</a>). The changes in the pulmonary vasculature associated with PH results in a significant increase in pulmonary arterial pressure and right ventricular afterload during exercise (<a href="./references#CD011285-bbs2-0105" title="ProvencherS , HerveP , SitbonO , HumbertM , SimonneauG , ChemlaD . Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. European Respiratory Journal2008;32(2):393-8.">Provencher 2008</a>; <a href="./references#CD011285-bbs2-0109" title="RileyMS , PorszaszJ , EngelenMP , ShapiroSM , BrundageBH , WassermanK . Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide. Journal of the American College of Cardiology2000;36(2):547-56.">Riley 2000</a>). Right ventricular contractility is decreased and there is a reduced capacity for stroke volume and, therefore, for cardiac output to increase during exercise (<a href="./references#CD011285-bbs2-0080" title="FowlerRM , GainKR , GabbayE . Exercise intolerance in pulmonary arterial hypertension. Pulmonary Medicine2012;10:359204. [DOI: 10.1155/2012/359204]">Fowler 2012</a>). Moreover, people with PH have a reduced heart rate response to exercise (chronotropic incompetence), which further decreases the ability for cardiac output to increase during exercise (<a href="./references#CD011285-bbs2-0104" title="ProvencherS , ChemlaD , HerveP , SitbonO , HumbertM , SimonneauG . Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. European Respiratory Journal2006;27(1):114-20.">Provencher 2006</a>). As a result, people with PH have a blunted increase in cardiac output during exercise that significantly reduces peak oxygen transport. In the periphery, people with PH appear to have marked skeletal muscle dysfunction consistent with a reduced oxidative capacity (<a href="./references#CD011285-bbs2-0093" title="MainguyV , MaltaisF , SaeyD , GagnonP , MartelS , SimonM , et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax2010;65(2):113-7.">Mainguy 2010a</a>). Compared to healthy people, people with PH had a lower percentage of Type I fibres and increased concentrations of enzymes associated with glycolytic (anaerobic) metabolism (<a href="./references#CD011285-bbs2-0093" title="MainguyV , MaltaisF , SaeyD , GagnonP , MartelS , SimonM , et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax2010;65(2):113-7.">Mainguy 2010a</a>). These central and peripheral changes would result in a substantial reduction in the ability to transport and utilise oxygen during exercise, resulting in a significant decrease in exercise capacity. </p> <p>In people with chronic lung disease, lower limb exercise training and strength training have both been demonstrated to increase exercise capacity and quality of life (<a href="./references#CD011285-bbs2-0113" title="SpruitMA , SinghSJ , GarveyC , ZuWallackR , NiciL , RochesterC , et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine2013;188(8):e13-64.">Spruit 2013</a>). The primary site of adaptation appears to be the skeletal muscle, with little change in cardiac function following exercise training in people with chronic heart and lung disease (<a href="./references#CD011285-bbs2-0116" title="VogiatzisI , ZakynthinosS . The physiological basis of rehabilitation in chronic heart and lung disease. Journal of Applied Physiology2013;115(1):16-21.">Vogiatzis 2013</a>). For example, in people with chronic obstructive pulmonary disease there is evidence that exercise training results in improved skeletal muscle structure and function with little change in cardiac function (<a href="./references#CD011285-bbs2-0116" title="VogiatzisI , ZakynthinosS . The physiological basis of rehabilitation in chronic heart and lung disease. Journal of Applied Physiology2013;115(1):16-21.">Vogiatzis 2013</a>; <a href="./references#CD011285-bbs2-0118" title="WhittomF , JobinJ , SimardPM , LeblancP , SimardC , BernardS , et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Medicine and Science in Sports and Exercise1998;30(10):1467-74.">Whittom 1998</a>). Whilst preliminary evidence in a few people suggests that there is some improvement in skeletal muscle function following exercise training in PH (<a href="./references#CD011285-bbs2-0078" title="deManFS , HandokoML , GroepenhoffH , van't HulAJ , AbbinkJ , KoppersRJ , et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. European Respiratory Journal2009;34(3):669-75.">de Man 2009</a>; <a href="./references#CD011285-bbs2-0094" title="MainguyV , MaltaisF , SaeyD , GagnonP , MartelS , SimonM , et al. Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation2010;30(5):319-23.">Mainguy 2010b</a>), it remains unclear if these changes result in improved exercise capacity or if they relate to improved long‐term outcomes. Currently, there is limited evidence for any central changes following exercise training in PH. </p> </section> <section id="CD011285-sec-0013"> <h3 class="title" id="CD011285-sec-0013">Why it is important to do this review</h3> <p>A previous Cochrane Review was undertaken in 2017 (<a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>). Whilst this review reported that exercise‐based rehabilitation resulted in an improvement in exercise capacity and was not associated with any adverse events, it only included six studies and that the quality of the evidence was low. Additional studies examining the efficacy of exercise‐based rehabilitation have now been published and some international societies have begun providing specific guidelines regarding exercise‐based rehabilitation in PH. The Thoracic Society of Australia and New Zealand recommended exercise training for PH in their 2017 guidelines for pulmonary rehabilitation (<a href="./references#CD011285-bbs2-0070" title="AlisonJA , McKeoughZJ , JohnstonK , McNamaraRJ , SpencerLM , JenkinsSC , et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology2017;22(4):800-19.">Alison 2017a</a>); however, it was noted that this was a weak recommendation based on low‐certainty evidence. More recently, the European Respiratory Society published a statement on exercise training in PH reporting improvements in exercise capacity, muscular function, quality of life and potentially right ventricular function (<a href="./references#CD011285-bbs2-0086" title="GrünigE , EichstaedtC , BarberàJA , BenjaminN , BlancoI , BossoneE , et al. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. European Respiratory Journal2019;53(2):1800332. [DOI: 10.1183/13993003.00332-2018]">Grunig 2019a</a>). However, it was noted that further studies were needed to consolidate these findings and the impact of exercise training on disease risk profiles and to establish optimal training methodology. Indeed, the most recent European Cardiac and Respiratory Societies Guidelines for the diagnosis and treatment of PH recommend supervised exercise training for people with PAH under medical therapy (Class of recommendation: 1; level of evidence A) (<a href="./references#CD011285-bbs2-0092" title="HumbertM , KovacsG , HoeperMM , BadagliaccaR , BergerRM , BridaM , et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal2022;60(6):2200879. [DOI: 10.1183/13993003.00879-2022]">Humbert 2022</a>). With the broadening of international acceptance of exercise training in PH, albeit based on a limited body of evidence, the purpose of this review was to consolidate the current evidence on exercise‐based rehabilitation in PH and examine both efficacy and safety of the intervention. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011285-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011285-sec-0014"></div> <p>To evaluate the benefits and harms of exercise‐based rehabilitation for people with PH compared with usual care or no exercise‐based rehabilitation. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011285-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011285-sec-0015"></div> <section id="CD011285-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011285-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs). We included studies reported in full or abstract form as well as any relevant, unpublished data. </p> </section> <section id="CD011285-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included adults with a diagnosis of PH. We included all five clinical groups of PH (<a href="./references#CD011285-bbs2-0112" title="SimonneauG , MontaniD , CelermajerDS , Denton CP Gatzoulis MA, KrowkaM , et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal2019;53:1801913.">Simonneau 2019</a>), independent of whether the participants were stable on therapy (i.e. change of therapy over the past three months). </p> </section> <section id="CD011285-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing exercise‐based rehabilitation with usual care or no exercise‐based rehabilitation. Exercise‐based rehabilitation of any frequency and duration was eligible for inclusion, including inpatient, outpatient or home‐based settings. We included exercise programmes of any length; however, we only included trials in which exercise training was supervised. We excluded exercise programmes that only provided exercise advice. We included exercise‐based programmes prescribing aerobic or strength training, or both. </p> <p>We planned to analyse exercise‐rehabilitation that only included a strength‐training programme separately; however, we found no such trials. </p> <p>The control group included individuals randomised to a programme of education or usual care that had no specific exercise prescription component. </p> </section> <section id="CD011285-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD011285-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>All outcome measures were reported immediately prior to the intervention being commenced (before measurement) and immediately after the completion of the exercise‐based intervention or control period. </p> <p> <ul id="CD011285-list-0002"> <li> <p>Exercise capacity</p> <ul id="CD011285-list-0003"> <li> <p>Measures of exercise capacity included, but were not confined to, outcomes such as the six‐minute walk distance (6MWD), peak exercise capacity (VO<sub>2peak</sub>), peak power (W<sub>peak</sub>) and measures derived during the assessment of exercise capacity such as breathing efficiency (V<sub>E</sub>/VCO<sub>2</sub> slope) and anaerobic threshold </p> </li> </ul> </li> <li> <p>Serious adverse events during the intervention period. We used this measure to assess the short‐term safety of exercise training in PH. We defined adverse events as: </p> <ul id="CD011285-list-0004"> <li> <p>mortality during the exercise/control intervention period;</p> </li> <li> <p>disease progression, defined according to the investigators' definition;</p> </li> <li> <p>symptoms precluding training, such as illness, lightheadedness, syncope or presyncope; and </p> </li> <li> <p>discontinuation of the study</p> </li> </ul> </li> <li> <p>Health‐related quality of life (HRQoL) measured by any validated generic or disease‐specific quality‐of‐life measure </p> </li> </ul> </p> </section> <section id="CD011285-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011285-list-0005"> <li> <p>Cardiopulmonary haemodynamics</p> <ul id="CD011285-list-0006"> <li> <p>These included measures made using echocardiographic, right heart catheter or magnetic resonance imaging techniques </p> </li> <li> <p>Outcome measures included, but were not confined to, indices such as mPAP, mean pulmonary vascular resistance, right ventricular systolic pressure, tricuspid annular plane systolic excursion, ventricular ejection fraction, ventricular end diastolic volume and ventricular end systolic volume </p> </li> </ul> </li> <li> <p>Functional Class measured using the New York Heart Association (NYHA) Classification (<a href="./references#CD011285-bbs2-0098" title="Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Little, Brown &amp; Co, 1994.">NYHA 1994</a>) or World Health Organization (WHO) Functional Classification (<a href="./references#CD011285-bbs2-0110" title="RubinL . Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest2004;126:S7-S10.">Rubin 2004</a>) </p> </li> <li> <p>Clinical worsening during the follow‐up period</p> <ul id="CD011285-list-0007"> <li> <p>Impact of exercise training on clinical worsening assessed using the investigators definition </p> </li> <li> <p>Typically, clinical worsening was defined using a combination of outcomes including survival, hospitalisation due to PH, transplantation, requirement for additional pharmacological therapy, a reduction in Functional Class and or a reduction in 6MWD (<a href="./references#CD011285-bbs2-0081" title="FrostAE , BadeschDB , MillerDP , BenzaRL , MeltzerLA , McGoonMD . Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis. Chest2013;144(5):1521-9.">Frost 2013</a>) </p> </li> <li> <p>For the purpose of this study, we treated mortality during the follow‐up period as a separate secondary outcome measure </p> </li> </ul> </li> <li> <p>Mortality during the follow‐up period</p> <ul id="CD011285-list-0008"> <li> <p>We recorded all deaths reported following the exercise intervention</p> </li> <li> <p>We treated these deaths separately to those that occurred during the exercise training period, which were recorded by the primary outcome measure, serious adverse events </p> </li> </ul> </li> <li> <p>B‐type natriuretic peptide</p> <ul id="CD011285-list-0009"> <li> <p>A commonly used marker of right ventricular dysfunction in PH that is correlated with survival (<a href="./references#CD011285-bbs2-0074" title="CasserlyB , KlingerJR . Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Design, Development and Therapy2009;3:269-87.">Casserly 2009</a>) </p> </li> <li> <p>We examined changes in B‐type natriuretic peptide following exercise‐based rehabilitation</p> </li> </ul> </li> </ul> </p> <p>Reporting one of more of the outcomes listed here was not an inclusion criterion for the review. </p> </section> </section> </section> <section id="CD011285-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011285-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified trials from searches of the following databases:</p> <p> <ul id="CD011285-list-0010"> <li> <p>The Cochrane Airways Register of Trials;</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2021, issue 8) (via the Cochrane Register of Studies (CRSO); </p> </li> <li> <p>MEDLINE (Ovid);</p> </li> <li> <p>Embase (Ovid);</p> </li> <li> <p>Physiotherapy Evidence Database (PEDro).</p> </li> </ul> </p> <p>The database search strategies are listed in <a href="./appendices#CD011285-sec-0080">Appendix 1</a>. The previously published review included searches up to August 2016 and the search period for this most recent update was from the previous end date to 28 June 2022 with no restriction on language or type of publication. We handsearched conference abstracts and grey literature from the CENTRAL database. </p> </section> <section id="CD011285-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked reference lists of all primary studies and review articles for additional references. We searched for errata or retractions from included studies published in full text on PubMed. We conducted a search of ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>) and the WHO International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) (see <a href="./appendices#CD011285-sec-0080">Appendix 1</a> for search strategies). </p> </section> </section> <section id="CD011285-sec-0026"> <h3 class="title" id="CD011285-sec-0026">Data collection and analysis</h3> <section id="CD011285-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AH and NM for the previous review and JL and AJ in this updated search) independently screened titles and abstracts for inclusion and coded them as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We retrieved the full‐text study reports/publications, and two review authors (NM and AH) independently screened the full‐text, identified studies for inclusion, and identified and recorded reasons for exclusion of the ineligible studies. We resolved any disagreements through discussion. We identified and excluded duplicates and collated multiple reports of the same study so that each study rather than each report was the unit of interest in the review. We used Covidence to manage the selection process (<a href="./references#CD011285-bbs2-0076" title="Covidence. Version accessed prior to 8 November 2022. Melbourne, Australia: Veritas Health Innovation. Available at www.covidence.org.">Covidence</a>). We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (<a href="#CD011285-fig-0001">Figure 1</a>) and <a href="./references#CD011285-sec-0098" title="">Characteristics of excluded studies</a> table. </p> <div class="figure" id="CD011285-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow diagram." data-id="CD011285-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> </div> </section> <section id="CD011285-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form for study characteristics and outcome data that was piloted on one study in the review. Two review authors (AJ and JL) extracted study characteristics from included studies. </p> <p>We extracted the following study characteristics.</p> <p> <ul id="CD011285-list-0011"> <li> <p>Methods: study design, total duration of study, details of any 'run in' period, number of study centres and location, study setting, withdrawals and date of study. </p> </li> <li> <p>Participants: number enroled, mean age, age range, gender, severity of condition, diagnostic criteria, baseline echocardiography and right heart catheter data, baseline lung function, inclusion criteria and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, training dose (intensity, frequency and duration of exercise training), comparison, concomitant medications and excluded medications. </p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ul> </p> <p>We noted in the <a href="./references#CD011285-sec-0097" title="">Characteristics of included studies</a> table if outcome data were not reported in a usable way. We resolved disagreements by consensus. One review author (NM) transferred data into Cochrane's statistical software, Review Manager 5 (<a href="./references#CD011285-bbs2-0107" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). A second review author (AJ) spot‐checked study characteristics for accuracy against the trial report. </p> </section> <section id="CD011285-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (NM and AH for the previous review and JL and AJ in this updated search) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and the RoB 1 tool (<a href="./references#CD011285-bbs2-0088" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We resolved any disagreements by discussion. </p> <p>We assessed the risk of bias according to the following domains.</p> <p> <ul id="CD011285-list-0012"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other bias</p> </li> </ul> </p> <p>We graded each potential source of bias as high, low or unclear and provided a quote from the study report together with a justification for our judgement in the risk of bias table. We summarised the risk of bias judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes where necessary (e.g. for unblinded outcome assessment, risk of bias for all‐cause mortality may be very different from for a HRQoL scale). </p> <p>When considering treatment effects, we considered the risk of bias for the studies that contributed to that outcome. </p> <section id="CD011285-sec-0030"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol (<a href="./references#CD011285-bbs2-0122" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285]">Morris 2014</a>), and reported any deviations from it in the <a href="#CD011285-sec-0095">Differences between protocol and review</a> section of the systematic review. </p> </section> </section> <section id="CD011285-sec-0031"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as odds ratios (ORs), with 95% confidence intervals (CIs). For continuous data, we used mean differences (MDs) when studies used the same scales or standardised mean differences (SMDs) when studies used different scales, with 95% CIs. Where it was reported, we used the change from baseline. Where the change from baseline was not reported, we used the adjusted results or final score. We did not combine data expressed as change from baseline with that reported as other metrics. We entered data presented as a scale with a consistent direction of effect. </p> <p>We undertook meta‐analyses only where this was meaningful, that is, if the treatments, participants and the underlying clinical questions were similar enough for pooling to make sense. </p> <p>We narratively described skewed data reported as medians and interquartile ranges.</p> <p>Where a single trial reported multiple trial arms, we planned to include only the relevant arms; however, the search identified no trials of this nature. </p> </section> <section id="CD011285-sec-0032"> <h4 class="title">Unit of analysis issues</h4> <p>Where studies randomly allocated the participants to either the exercise‐based rehabilitation or control, we considered the participant as the unit of analysis. We excluded cross‐over trials due to the potential carry‐over effects of exercise training. </p> </section> <section id="CD011285-sec-0033"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial investigators or study sponsors to verify key study characteristics and obtain missing numerical outcome data where possible (e.g. when a study was identified as abstract only). Where this was not possible, and the missing data were thought to introduce serious bias, we explored the impact of including such studies in the overall assessment of results using a sensitivity analysis<b>.</b> </p> </section> <section id="CD011285-sec-0034"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I² statistic to measure heterogeneity amongst the trials in each analysis (<a href="./references#CD011285-bbs2-0087" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327:557-60.">Higgins 2003</a>). We classified heterogeneity as low when the I<sup>2</sup> statistic was less than 30%, moderate when the I<sup>2</sup> statistic was 30% to 50%, substantial when the I<sup>2</sup> statistic was 50% to 75% and considerable when the I<sup>2</sup> statistic was greater than 75%. If we identified substantial heterogeneity, we explored possible causes by prespecified subgroup analysis (<a href="./references#CD011285-bbs2-0077" title="DeeksJJ , HigginsJP , Altman DG on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Deeks 2011</a>). </p> </section> <section id="CD011285-sec-0035"> <h4 class="title">Assessment of reporting biases</h4> <p>If we were able to pool more than 10 trials, we created and examined a funnel plot to explore possible small‐study and publication biases. </p> </section> <section id="CD011285-sec-0036"> <h4 class="title">Data synthesis</h4> <p>We performed a pooled quantitative synthesis where the trials were clinically homogeneous. We pooled data using a random‐effects model to incorporate between‐study heterogeneity into the meta‐analysis. We used data from an intention‐to‐treat (ITT) analysis where available. Where the trials were clinically heterogeneous, we performed a narrative synthesis. We used RevMan HAL, developed by the Cochrane Schizophrenia Group to construct a first draft of the results section (<a href="https://schizophrenia.cochrane.org/revman-hal-v4" target="_blank">szg.cochrane.org/revman-hal)</a>. </p> </section> <section id="CD011285-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out the following subgroup analyses.</p> <p> <ul id="CD011285-list-0013"> <li> <p>Type of PH:</p> <ul id="CD011285-list-0014"> <li> <p>we analysed data separately for people with PAH only (Group 1).</p> </li> </ul> </li> <li> <p>Severity of PH:</p> <ul id="CD011285-list-0015"> <li> <p>we planned to compare the outcomes of less severe disease classification (NYHA Class I/II) with those with more severe disease classification (NYHA Class III/IV); however, there were insufficient data available. </p> </li> </ul> </li> </ul> </p> <p>We used the following outcomes in subgroup analyses:</p> <p> <ul id="CD011285-list-0016"> <li> <p>exercise capacity;</p> </li> <li> <p>serious adverse events;</p> </li> <li> <p>HRQoL.</p> </li> </ul> </p> <p>We used the formal test for subgroup interactions.</p> </section> <section id="CD011285-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses to examine the effects of methodological quality on the pooled estimate by removing studies that were at high or unclear risk of bias for the domains of blinding and incomplete outcome data. </p> </section> <section id="CD011285-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a summary of findings table using the following outcomes: exercise capacity, serious adverse events, HRQoL, cardiopulmonary haemodynamics, Functional Class, clinical worsening during follow‐up and mortality during the follow‐up period<i>.</i> We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the certainty of a body of evidence as it related to the studies that contributed data to the meta‐analyses for the prespecified outcomes. We used methods and recommendations described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011285-bbs2-0088" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>) using GRADEpro GDT software (<a href="./references#CD011285-bbs2-0085" title="GRADEpro GDT. Version accessed 23 September 2016. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). We justified all decisions to downgrade or upgrade the certainty of the evidence in the footnotes section of <a href="./full#CD011285-tbl-0001">summary of findings Table 1</a>, and we made comments to aid readers' understanding of the review where necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011285-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011285-sec-0040"></div> <section id="CD011285-sec-0041"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD011285-sec-0097" title="">Characteristics of included studies</a>; <a href="./references#CD011285-sec-0098" title="">Characteristics of excluded studies</a>; <a href="./references#CD011285-sec-0099" title="">Characteristics of studies awaiting classification</a> and <a href="./references#CD011285-sec-0100" title="">Characteristics of ongoing studies</a> tables for complete details. </p> <section id="CD011285-sec-0042"> <h4 class="title">Results of the search</h4> <p>The study flow diagram is shown in <a href="#CD011285-fig-0001">Figure 1</a>. This updated review includes 14 studies. The original review identified 2451 records which, following removal of duplicates and exclusion, resulted in the inclusion of six studies (<a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>). The most recent search covered August 2016 to February 2022 and identified 1868 new records. We identified one additional record through handsearching. After removing duplicates and exclusion of irrelevant titles or abstracts, we assessed 49 studies (73 records) for eligibility. Of these, 26 studies (39 records) were excluded from review (see <a href="./references#CD011285-sec-0098" title="">Characteristics of excluded studies</a> table for reasons). We identified eight new studies (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>), 11 studies are awaiting classification (<a href="./references#CD011285-bbs2-0056" title="NCT00477724. Incidence of latent pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension after endarterectomy and influence of exercise and respiratory therapy. clinicaltrials.gov/show/NCT00477724 (first received 24 May 2007). ">NCT00477724</a>; <a href="./references#CD011285-bbs2-0057" title="NCT00491309. Exercise and respiratory therapy in patients with rheumatoid arthritis / collagenosis and pulmonary hypertension. clinicaltrials.gov/ct2/show/NCT00491309 (first received 26 June 2007). ">NCT00491309</a>; <a href="./references#CD011285-bbs2-0058" title="NCT02558582. Effect of exercise training in patients with pulmonary hypertension [Effect of exercise training in arterial and chronic thromboembolic pulmonary hypertension in Switzerland and standardization with European countries]. clinicaltrials.gov/ct2/show/nct02558582 (first received 24 September 2015). ">NCT02558582</a>; <a href="./references#CD011285-bbs2-0059" title="NCT02579954. Cardiac function and exercise capacity in pulmonary arterial hypertension (FONCE-HTAP). clinicaltrials.gov/ct2/show/nct02579954 (first received 20 October 2015). ">NCT02579954</a>; <a href="./references#CD011285-bbs2-0060" title="NCT03045666. Impact of rehabilitation program on PAH patients treated with macitentan. clinicaltrials.gov/ct2/show/NCT03045666 (first received 7 February 2017). ">NCT03045666</a>; <a href="./references#CD011285-bbs2-0061" title="NCT03288025. Pulmonary arterial hypertension improvement with nutrition and exercise (PHINE) [Pulmonary arterial hypertension improvement with nutrition and exercise (PHINE): a randomized controlled trial]. clinicaltrials.gov/ct2/show/NCT03288025 (first received 19 September 2017). ">NCT03288025</a>; <a href="./references#CD011285-bbs2-0062" title="NCT03955016. Rehabilitation for patients with pulmonary hypertension [A randomized controlled trial to evaluate the effect of a rehabilitation program on the exercise capacity of patients with pulmonary hypertension]. clinicaltrials.gov/ct2/show/nct03955016 (first received 17 May 2019). ">NCT03955016</a>; <a href="./references#CD011285-bbs2-0063" title="NCT4188756. RV systolic and diastolic function and contractile reserve under acute exercise and in response to chronic exercise-based rehabilitation (Reserve). clinicaltrials.gov/show/NCT04188756 (first received 6 December 2019). ">NCT04188756</a>; <a href="./references#CD011285-bbs2-0064" title="NCT04224012. Effect of exercise and respiratory therapy on right ventricular function in severe pulmonary hypertension. clinicaltrials.gov/show/NCT04224012 (first received 13 January 2020. ">NCT04224012</a>; <a href="./references#CD011285-bbs2-0065" title="NCT04909008. Exercise training to improve cardiopulmonary hemodynamics in heart failure patients [Exercise training to improve pulmonary haemodynamic and right ventricular function in heart failure patients with pulmonary hypertension]. clinicaltrials.gov/show/NCT04909008 (first received 1 June 2021). ">NCT04909008</a>; <a href="./references#CD011285-bbs2-0066" title="NCT05242380. Exercise training in patients with pulmonary arterial hypertension [The effects of kettlebell exercise training in patients with pulmonary arterial hypertension]. ClinicalTrials.gov/show/NCT05242380 (first received 16 February 2022). ">NCT05242380</a>), and there are two ongoing studies (<a href="./references#CD011285-bbs2-0067" title="ISRCTN10608766. Supervised pulmonary hypertension exercise rehabilitation (sphere) trial [Supervised pulmonary hypertension exercise rehabilitation (SPHERe): a multi-centre randomized controlled trial]. www.isrctn.com/ISRCTNISRCTN10608766 (first received 13 March 2019). McGregorG , BruceJ , EnnisS , MasonJ , LallR , JiC , et al. Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial. BMC Pulmonary Medicine2020;20(1):143. [DOI: 10.1186/s12890-020-01182-y]">McGregor 2020</a>; <a href="./references#CD011285-bbs2-0068" title="ACTRN12616001467426. Exercise training in pulmonary hypertension [Exercise training in pulmonary hypertension (ExTra_PH): a randomised controlled trial examining short and long-term outcomes of an outpatient-based exercise training in pulmonary hypertension]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12616001467426 (first received 21 October 2016). MorrisNR , LouisM , StrugnellW , HarrisJ , LinA , FeenstraJ , et al. Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH). BMC Pulmonary Medicine2018;18(1):40. [DOI: 10.1186/s12890-018-0586-8]">Morris 2018</a>). Two studies (four records) that were included in the previous review were moved to previous included or excluded studies) (<a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>). </p> </section> <section id="CD011285-sec-0043"> <h4 class="title">Included studies</h4> <p>We included 14 studies (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>; see <a href="./references#CD011285-sec-0097" title="">Characteristics of included studies</a> table). </p> <p>A summary of the included studies is provided in <a href="#CD011285-tbl-0002">Table 1</a>. All included studies were parallel‐group RCTs. The total number of included participants across all studies was 571 (intervention and control groups). Study sample sizes ranged from 10 (<a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>) to 129 (<a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>) participants. Only one was a multicentred trial (<a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>), with all others being single‐centred trials. Most participants had PAH (Group 1 PH) or CTEPH. The mean age of participants ranged from 35 to 68 years, and the group mPAP on right heart catheterisation ranged from 40 mmHg to 62 mmHg. All included participants were classified as being stable on medical therapy. Most study participants completed at least part of their rehabilitation programme in an inpatient setting (61% of the included participants: <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). In addition to supervised exercise training, nine studies also included an unsupervised home‐based component (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). Inpatient exercise training was typically performed daily whereas outpatient and home‐based exercise training was undertaken three to five times per week. Exercise training typically consisted of aerobic exercise of the lower limbs using either cycling or walking on a treadmill, or overground. Exercise intensity was regulated with heart rate or using rating of perceived exertion. Whilst there were no studies that only implemented a strength training protocol, most studies included both upper and lower limb strength training within the exercise protocol. All studies reported measuring exercise capacity with 12 studies using the 6MWD and eight studies using a cardiopulmonary exercise test (CPET). <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a> reported using the incremental shuttle walk to measure changes in exercise capacity. Most studies reported changes in HRQoL, with the 36‐item Short‐Form (SF‐36) the most commonly measurement tool. </p> <div class="table" id="CD011285-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study characteristics</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study design (grouping)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant age (years), gender</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pulmonary arterial pressure (mmHg)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Duration of programme</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Delivery mode: inpatient/ outpatient/ home</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Exercise modality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Training dose (frequency/duration)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Training intensity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome measures</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Funding sources</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 15 (1 withdrawal)</p> <p>Control: 15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 48 (SD 7)</p> <p>Control: 47 (SD 8)</p> <p>Gender: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP: unclear</p> <p>PASP:</p> <p>Exercise: 58 (SD 15)</p> <p>Control: 58 (SD 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0017"> <li> <p>Aerobic exercise (cycle ergometer)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 15–30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 min at lower workload (e.g. 20 W) and 1 min at higher workload (e.g. 35 W).</p> <p>60–70% of heart rate reserve; 60–70% of VO<sub>2</sub> max </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0018"> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>PASP</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cairo University</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 10 (1 withdrawal)</p> <p>Control: 9 (2 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 61.6 (SD 18.5)</p> <p>Control: 68.3 (SD 16.6)</p> <p>Gender: (male/female)</p> <p>Exercise: 1/8</p> <p>Control: 0/7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 44.1 (SD 15.7)</p> <p>Control: 49.1 (SD 14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Home.</p> <p>Training supervised at the centre in weeks 1, 4 and 12; home‐based training with weekly telephone consultation for the remainder </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0019"> <li> <p>Aerobic exercise (walking, cycle ergometer)</p> </li> <li> <p>Strength exercise</p> </li> <li> <p>Inspiratory muscle training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p> <ul id="CD011285-list-0020"> <li> <p>Aerobic exercise: 3 times/week</p> </li> <li> <p>Strength exercise: 2 times/week</p> </li> <li> <p>Inspiratory muscle training: 5 times/week</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0021"> <li> <p>Aerobic exercise: 20–40 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0022"> <li> <p>Aerobic exercise: 5–6 on Borg scale; sustained SpO<sub>2</sub> or decrease of &lt; 5% from the baseline value. Progression was based on individual tolerability and provided by an increase in training duration and limited by 'alarm signs' (i.e. peak heart rate: &gt; 120 bpm; maximal decrease in SpO<sub>2</sub> of 85%; perceived exertion &gt; 6 and subjective symptoms of exercise intolerance) </p> </li> <li> <p>Strength exercise: 5–10 reps each set using bodyweight or low weights (0.5–1 kg)</p> </li> <li> <p>Inspiratory muscle training: 3 × 3 to 3 × 7 reps each set; 30–70% from max resistance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0023"> <li> <p>6MWD</p> </li> <li> <p>Sleep Quality: Pittsburgh Sleep Quality Index</p> </li> <li> <p>HADS</p> </li> <li> <p>Inspiratory Pressure Test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 10</p> <p>Control: 13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 53 (SD 13)</p> <p>Control: 55.5 (SD 8.5)</p> <p>Gender: (male/female)</p> <p>Exercise: 0/10</p> <p>Control: 0/13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 40.3 (SD 13.8)</p> <p>Control: 43.8 (SD 14.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0024"> <li> <p>Aerobic exercise (treadmill walking)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>2–3 times/week</p> <p>Training duration: 30–45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70–80% of heart rate reserve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0025"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> <li> <p>HRQoL (CAMPHOR): Symptoms</p> </li> <li> <p>HRQoL (CAMPHOR): Activities</p> </li> <li> <p>HRQoL (CAMPHOR): QoL</p> </li> <li> <p>NYHA Class</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US National Institutes of Health</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 46</p> <p>Control: 41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 55 (SD 15)</p> <p>Control: 57 (SD 15)</p> <p>Gender: (male/female)</p> <p>Exercise: 20/26</p> <p>Control: 20/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 41 (SD 11.7)</p> <p>Control: 37.6 (SD 11.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient (3 weeks)</p> <p>Outpatient (unsupervised; performed at home; 12 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0026"> <li> <p>Aerobic exercise (interval bicycle ergometer, walking)</p> </li> <li> <p>Resistance exercise</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>Inpatient:</p> <p> <ul id="CD011285-list-0027"> <li> <p>Aerobic exercise: walking and cycling: 7 days/week</p> </li> <li> <p>Resistance exercise: 5 days/week</p> </li> <li> <p>Respiratory exercise: 5 days/week</p> </li> </ul> </p> <p>Outpatient (performed at home):</p> <p> <ul id="CD011285-list-0028"> <li> <p>Aerobic exercise: cycling: 5 times/week; walking: twice/week</p> </li> <li> <p>Resistance exercise: second daily</p> </li> <li> <p>Respiratory training: second daily</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0029"> <li> <p>Aerobic exercise: cycle ergometer: 10–25 min; walking: 60 min</p> </li> <li> <p>Resistance exercise: 30 min</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60–80% of heart rate reserve</p> <p>Heart rate maintained at &lt; 120 bpm; oxygen saturation maintained at &gt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0030"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>W<sub>peak</sub> </p> </li> <li> <p>Morbidity – adverse events</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Precluded from training</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>Discontinued training</p> </li> <li> <p>mPAP (mmHg)</p> </li> <li> <p>PVR (dynes)</p> </li> <li> <p>Cardiac output (L/min)</p> </li> <li> <p>NT‐proBNP</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Centre for Pulmonary Hypertension, Thorax clinic at the University of Heidelberg, Germany </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 15 (3 withdrawals)</p> <p>Control: 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 49.6 (SD 9.9)</p> <p>Control: 44.3 (SD 9.4)</p> <p>Gender: (male/female)</p> <p>Exercise: 2/10</p> <p>Control: 3/9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 47.2 (SD 18.8)</p> <p>Control: 40.5 (SD 18.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient twice/week</p> <p>Home (unsupervised) once/week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0031"> <li> <p>Ground‐based walking training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: ≥ 3 times/week (2 days at hospital and ≥ 1 at home)</p> <p>Training duration: initially 30 min; then increased by 5 min once every 2 weeks to a max of 45 min after 8 weeks depending on exercise tolerance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical symptom scores were used to determine</p> <p>exercise intensity</p> <p>Heart rate maintained at 120 bpm; perceived exertion level at 3–4 on modified Borg scale </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0032"> <li> <p>Endurance Shuttle Walk Test</p> </li> <li> <p>Incremental Shuttle Walk Test</p> </li> <li> <p>6MWD</p> </li> <li> <p>HRQoL (EmPHasis‐10)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Istanbul University – Cerrahpasa Scientific Research Projects Unit</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 5</p> <p>Control: 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 51 (range 40–53)</p> <p>Control: 53 (range 42–57)</p> <p>Gender: (male/female)</p> <p>Exercise: 0/5</p> <p>Control: 1/4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 23 (range 19–29)</p> <p>Control: 49 (range 20–65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient, supervised sessions.</p> <p>Commenced 1 home‐based unsupervised session/week in last 4 weeks of supervised programme; then asked to continue with home programme (unsupervised) for an additional 12 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0033"> <li> <p>Lower limb endurance training (walking and cycling)</p> </li> <li> <p>Lower limb functional strength training (step ups and sit to stands) Endurance training of the upper limbs </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60–70% of heart rate max (based on age predicted max, 220 – age); SpO<sub>2</sub> maintained at ≥ 92%; &lt; 4 on Borg scale </p> <p>Exercise intensity progressed based on the individual's response to training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0034"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>W<sub>peak</sub> </p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (CAMPHOR): Symptoms</p> </li> <li> <p>HRQoL (CAMPHOR): Activities</p> </li> <li> <p>HRQoL (CAMPHOR): QoL</p> </li> <li> <p>Morbidity</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Symptoms precluding training</p> </li> <li> <p>Discontinued training</p> </li> <li> <p>NYHA class</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Advanced Lung Disease Unit at Royal Perth Hospital and the Lung Institute of Western Australia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 20 (1 withdrawal)</p> <p>Control: 20 (4 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 46 (SD 11)</p> <p>Control: 45 (SD 12)</p> <p>Gender: (male/female)</p> <p>Exercise: 12/8</p> <p>Control: 12/8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 47 (SD 15)</p> <p>Control: 47 (SD 14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0035"> <li> <p>Aerobic training (cycling)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Inspiratory muscle training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p> <ul id="CD011285-list-0036"> <li> <p>Aerobic training: 5 times/week</p> </li> <li> <p>Resistance training: 3 times/week</p> </li> <li> <p>Inspiratory muscle training: twice daily, 6 days/week</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0037"> <li> <p>Aerobic training: 20–40 min</p> </li> <li> <p>Inspiratory muscle training: 5 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0038"> <li> <p>Aerobic training: Exercise‐rest intervals at a 1:1 ratio; 50% of the power output eliciting the anaerobic threshold during baseline assessment, with aim to reach 40 min (with about 15 min at the anaerobic threshold) during weeks 4–8 </p> </li> <li> <p>Resistance training: initial load of 6–8 in the 0–10 OMNI resistance exercise scale. The number of reps for each exercise was decreased with corresponding increases in load (kg) – 15 (weeks 1–2), 12 (weeks 3–4), 10 (weeks 5–6) and 8 reps (weeks 6–8) </p> </li> <li> <p>Inspiratory muscle training: 30 inspirations performed through a specific pressure‐load device against 40% of PI<sub>max</sub>, which was assessed each week to adjust the weekly load </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0039"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Adverse events</p> </li> <li> <p>HRQoL (SF‐36)</p> </li> <li> <p>NT‐proBNP</p> </li> <li> <p>5 Sit‐to‐Stand test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cátedra Real Madrid‐Universidad</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 68 (10 did not complete primary end point)</p> <p>Control: 61 (3 did not complete primary end point)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 52 (SD 12)</p> <p>Control: 55 (SD 13)</p> <p>Gender: (male/female)</p> <p>Exercise: 40/18</p> <p>Control: 45/13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 46.5 (SD 15.5) (n = 55)</p> <p>Control: 46.7 (SD 14.9) (n = 51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10–30 days (inpatient)</p> <p>11–12 weeks (home, unsupervised)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0040"> <li> <p>Aerobic training (cycle ergometer, guided walks)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Respiratory therapy</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>Inpatient: 5–7 days/week</p> <p>Home: 3–7 days/week</p> <p>Training duration:</p> <p> <ul id="CD011285-list-0041"> <li> <p>Cycle ergometer training: 10–25 min</p> </li> <li> <p>Guided walks: 60 min</p> </li> <li> <p>Resistance training: 30 min</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40–60% peak workload</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0042"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Wpeak</p> </li> <li> <p>WHO Functional Class</p> </li> <li> <p>NT‐proBNP</p> </li> <li> <p>SF‐36</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Echocardiography at rest and during exercise</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fondo Europeo de Desarrollo Regional (FEDER), EU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 16 (4 withdrawals)</p> <p>Control: 16 (6 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 54.7 (SD 15.6)</p> <p>Control: 53.1 (SD 12.1)</p> <p>Gender: (male/female)</p> <p>Exercise: 6/6</p> <p>Control: 3/7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 42.3 (SD 15.5)</p> <p>Control: 53.1 (SD 12.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0043"> <li> <p>Aerobic exercise (treadmill walking, cycling)</p> </li> <li> <p>Strengthening exercise</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 45–60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0044"> <li> <p>Aerobic exercise: 60–80% of the heart rate reached at peak oxygen uptake during initial exercise testing </p> </li> <li> <p>Strengthening exercise: 2 sets of 8–12 reps</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0045"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>VCO<sub>2</sub> </p> </li> <li> <p>V<sub>E</sub> </p> </li> <li> <p>V<sub>E</sub>/VCO<sub>2</sub> slope </p> </li> <li> <p>Resting blood pressure</p> </li> <li> <p>Resting heart rate</p> </li> <li> <p>Body surface area</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> <li> <p>State Trait Inventory</p> </li> <li> <p>Becks Depression Inventory</p> </li> <li> <p>Timed Up and Go Test</p> </li> <li> <p>Grip strength</p> </li> <li> <p>Lower limb strength</p> </li> <li> <p>Sit‐to‐Stand Test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 10</p> <p>Control: 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 47 (SD 8)</p> <p>Control: 54 (SD 14)</p> <p>Gender: (male/female)</p> <p>Exercise: 2/8</p> <p>Control: 4/6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 48 (SD 19)</p> <p>Control: 50 (SD 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0046"> <li> <p>Aerobic training (cycle ergometer, walking)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p> <ul id="CD011285-list-0047"> <li> <p>Cycle ergometry: daily</p> </li> <li> <p>Walking: daily</p> </li> <li> <p>Resistance training: 5 times/week</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0048"> <li> <p>Cycle ergometry: 10–25 min/day</p> </li> <li> <p>Walking: 60 min/day</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0049"> <li> <p>Aerobic training: commence at 60–80% of heart rate reserve; progress as per individual tolerability and improvement </p> </li> <li> <p>Resistance training: light weights (0.5–1 kg)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0050"> <li> <p>Morbidity – adverse events</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Precluded from training</p> </li> <li> <p>6MWD</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German National Research Agency</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 15</p> <p>Control: 15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 47 (SD 12)</p> <p>Control: 53 (SD 14)</p> <p>Gender: (male/female)</p> <p>Exercise: 5/10</p> <p>Control: 5/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 49.5 (SD 17.6)</p> <p>Control: 49.6 (SD 12.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks (inpatient)</p> <p>12 weeks (outpatient)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/home (unsupervised)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0051"> <li> <p>Aerobic training (cycle ergometer, walking)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>Inpatient:</p> <p> <ul id="CD011285-list-0052"> <li> <p>Cycle ergometer: 7 days/week</p> </li> <li> <p>Walking: 7 days/week</p> </li> <li> <p>Resistance training: 5 days/week</p> </li> <li> <p>Respiratory training: 5 days/week</p> </li> </ul> </p> <p>Outpatient:</p> <p> <ul id="CD011285-list-0053"> <li> <p>Cycle ergometer: 5 times/week</p> </li> <li> <p>Walking: twice/week</p> </li> <li> <p>Resistance training: second daily</p> </li> <li> <p>Respiratory training: second daily</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0054"> <li> <p>Cycle ergometer: 10–25 min Walking: 60 min</p> </li> <li> <p>Resistance training: 30 min</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0055"> <li> <p>Aerobic training: 60–80% of heart rate reserve; heart rate maintained at &lt; 120 bpm; oxygen saturation &gt; 85% </p> </li> <li> <p>Resistance training: low weights (0.5–1 kg)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0056"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>W<sub>peak</sub> </p> </li> <li> <p>Morbidity – adverse events</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Precluded from training</p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL(SF‐36): Mental Component Summary Score</p> </li> <li> <p>HRQoL (CAMPHOR): QoL</p> </li> <li> <p>NYHA Functional Class</p> </li> <li> <p>Discontinued training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German Pulmonary</p> <p>Hypertension Group, Pulmonale Hypertonie e.V., Rheinstetten, Germany</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 20 (1 withdrawal)</p> <p>Control: 19 (3 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 37.5 (SD 8.8)</p> <p>Control: 35.5 (SD 10.4)</p> <p>Gender: (male/female)</p> <p>Exercise: 1/19</p> <p>Control: 2/16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 61.4 (SD 14.2)</p> <p>Control: 56.8 (SD 11.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks (inpatient)</p> <p>10 weeks (outpatient)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient (supervised every 2 weeks), home (3 times/week, unsupervised)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0057"> <li> <p>Treadmill walking (inpatient)</p> </li> <li> <p>Walking on level ground (outpatient)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 30 min (inpatient); continuous or 2 × 15 min or 3 × 10 min (outpatient)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60–70% of the max heart rate by age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0058"> <li> <p>6MWD</p> </li> <li> <p>EQ‐5D‐3L (EuroQol)</p> </li> <li> <p>Utility Index</p> </li> <li> <p>NT‐proBNP</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Universitas Gadjah Mada,</p> <p>Jogjakarta, Indonesia</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 18</p> <p>Control: 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age: unclear</p> <p>Gender: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient/home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0059"> <li> <p>No specific details, exercise tailored to participant's needs</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single 1‐to‐1 class with a physiotherapist followed by home training using exercise prescription. Follow‐up telephone support was provided throughout the intervention period </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise tailored to participant's needs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0060"> <li> <p>Incremental Shuttle Walk Test</p> </li> <li> <p>Endurance Shuttle Walk Test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Royal Hallamshire Hospital, Sheffield, UK</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 23 (2 refused intervention, 4 lost to follow‐up, 1 excluded from</p> <p>analysis)</p> <p>Control: 23 (23 lost to follow‐up due to COVID‐19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 48.9 (SD 18.3)</p> <p>Control: 53.7 (SD 12.8)</p> <p>Gender: (male/female)</p> <p>Exercise: 9/7</p> <p>Control: 10/13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 47.2 (SD 14.9)</p> <p>Control: 49.1 (SD 14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0061"> <li> <p>Interval march training</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 5 days/week, once/day</p> <p>Training duration: March training: &gt; 30 min interrupted every 2 minutes by 1 of 5 respiratory exercises </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4–5 on modified Borg scale; 60–70% of heart rate reserve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0062"> <li> <p>6MWD</p> </li> <li> <p>PI<sub>max</sub> </p> </li> <li> <p>P<sub>Emax</sub> </p> </li> <li> <p>Grip strength</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical University of Bialystok, Bialystok, Poland</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>6MWD: six‐minute walk distance; bpm: beats per minute; EQ‐5D‐3L: European Quality of Life 5 Dimensions 3 Level Version; HADS: Hospital Anxiety Depression Scale; HRQoL: health‐related quality of life; max: maximum; min: minute; mPAP: mean pulmonary arterial pressure; n: number; NT‐proBNP: N‐terminal pro‐brain natriuretic peptide; NYHA: New York Heart Association; PASP: pulmonary arterial systolic pressure; P<sub>Emax</sub>: maximal expiratory pressure; PI<sub>max</sub>: maximal inspiratory pressure; PVR: pulmonary vascular resistance; QoL: quality of life; RCT: randomised controlled trial; rep: repetition; SD: standard deviation; SpO<sub>2</sub>: oxygen saturation; V<sub>E</sub>: pulmonary ventilation; VCO<sub>2</sub>: carbon dioxide production; VO<sub>2peak</sub>: peak oxygen capacity; W<sub>peak</sub>: peak workload; WHO: World Health Organization. </p> </div> </div> </section> <section id="CD011285-sec-0044"> <h4 class="title">Excluded studies</h4> <p>The current review excluded 41 studies (<a href="./references#CD011285-bbs2-0015" title="AlbarratiA , TaherM , NazerR . Effect of inspiratory muscle training on respiratory muscle strength and functional capacity in patients with type 2 diabetes mellitus: a randomized clinical trial. Journal of Diabetes2021;13(4):292-8. ">Albarrati 2021</a>; <a href="./references#CD011285-bbs2-0016" title="AslanGK , AkıncıB , YeldanI , OkumusG . A randomized controlled trial on inspiratory muscle training in pulmonary hypertension: effects on respiratory functions, functional exercise capacity, physical activity, and quality of life. Heart and Lung2020;49:381-7. AslanGK , AkinciB , YeldanI , DeveliEU , OkumusG . Inspiratory muscle training in patients with pulmonary hypertension: pilot study. European Respiratory Journal2017;50(Suppl 61):PA3455. NCT03385733. Inspiratory muscle training in pulmonary hypertension [The effects of inspiratory muscle training on exercise capacity, physical activity and quality of life in pulmonary hypertension]. clinicaltrials.gov/ct2/show/NCT03385733 (first received 28 December 2017). ">Aslan 2020</a>; <a href="./references#CD011285-bbs2-0017" title="BabuAS , PadmakumarR , MaiyaAG . A review of ongoing trials in exercise based rehabilitation for pulmonary arterial hypertension. Indian Journal of Medical Research2013;137(5):900-6. ">Babu 2013</a>; <a href="./references#CD011285-bbs2-0018" title="BabuAS , PadmakumarR , MaiyaAG . Effects of the pulmonary hypertension manual (PulHMan) on awareness of exercise among patients with pulmonary hypertension. World Congress of Cardiology Scientific Sessions; 2014 May 4-7; Melbourne, Australia. ">Babu 2014</a>; <a href="./references#CD011285-bbs2-0019" title="BabuA , MaiyaAG , PadmakumarR . Effects of home based exercise training on functional capacity and quality of life in group 1 pulmonary hypertension: a sub-analysis from a randomized trial. Journal of Cardiopulmonary Rehabilitation and Prevention2018;38(6):E23. BabuAS , PadmakumarR , NayakK , ShettyR , MohapatraAK , MaiyaAG . Effects of home-based exercise training on functional outcomes and quality of life in patients with pulmonary hypertension: a randomized clinical trial. Indian Heart Journal2019;71:161-5. BabuAS , RamachandranP , MaiyaAG . Effects of home-based exercise training in Eisenmenger's syndrome: secondary analysis from a RCT. Journal of Cardiopulmonary Rehabilitation and Prevention2017;37(5):367-8. ">Babu 2019</a>; <a href="./references#CD011285-bbs2-0020" title="BarbosaPB , FerreiraEM , ArakakiJS , TakaraLS , MouraJ , NascimentoRB , et al. Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension. European Journal of Applied Physiology2011;111(8):1851-61. [DOI: 10.1007/s00421-010-1799-6]">Barbosa 2011</a>; <a href="./references#CD011285-bbs2-0021" title="Becker-GruenigT , EhlkenN , GorenfloM , HagerA , HalankM , LichtblauM , et al. Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. ESC Congress; 2012 25-28 Aug; Munich, Germany. Becker-GrunigT , KloseH , EhlkenN , LichtblauM , NagelC , FischerC , et al. Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease. International Journal of Cardiology2013;168(1):375-81. ">Becker‐Grunig 2013</a>; <a href="./references#CD011285-bbs2-0022" title="BernheimAM , KienckeS , FischlerM , DorschnerL , DebrunnerJ , MairbäurlH , et al. Acute changes in pulmonary artery pressures due to exercise and exposure to high altitude do not cause left ventricular diastolic dysfunction. Chest2007;132(2):380-7. [DOI: 10.1378/chest.07-0297]">Bernheim 2007</a>; <a href="./references#CD011285-bbs2-0023" title="BhasipolA , SanjaroensuttikulN , PornsuriyasakP , YamwongS , TangcharoenT . Efficiency of the home cardiac rehabilitation program for adults with complex congenital heart disease. Congenital Heart Disease2018;13:952-8. ">Bhasipol 2018</a>; <a href="./references#CD011285-bbs2-0024" title="ChiaKS , FauxSG , WongPK , HollowayC , AssarehH , McLachlanCS , et al. Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol. BMJ Open2017;93(25):e129. ">Chia 2017</a>; <a href="./references#CD011285-bbs2-0025" title="DowmanLM , McDonaldCF , HillCJ , LeeAL , BarkerK , BooteC , et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax2017;72:210-9. ">Dowman 2017</a>; <a href="./references#CD011285-bbs2-0026" title="EhlkenN , VerduynC , TiedeH , StaehlerG , KargerG , NechwatalR , et al. Economic evaluation of exercise training in patients with pulmonary hypertension. Lung2014;192(3):359-66. [DOI: 10.1007/s00408-014-9558-9]">Ehlken 2014</a>; <a href="./references#CD011285-bbs2-0027" title="Farias da FontouraF , RoncatoG , WatteG , Brum SpilimbergoF , Bohns MeyerGM , RigattoK , et al. Effects of inspiratory muscle training on the sensation of dyspnea in patients with pulmonary hypertension group I and IV – randomized controlled clinical trial. European Respiratory Journal2018;62:PA1718. ">Farias da Fontoura 2018</a>; <a href="./references#CD011285-bbs2-0028" title="FoxBD , KassirerM , WeissI , RavivY , PeledN , ShitritD , et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. Journal of Cardiac Failure2011;17(3):196-200. ">Fox 2011</a>; <a href="./references#CD011285-bbs2-0029" title="FukuiS , OgoT , TakakiH , UedaJ , TsujiA , MoritaY , et al. Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Heart2016;102(17):1403-9. FukuiS , OgoT , UedaJ , TsujiA , KumasakaL , ArakawaT , et al. One year sustaining of combined effects of cardiac rehabilitation and balloon pulmonary angioplasty on exercise capacity in patients with inoperable chronic thromboembolic pulmonary hypertension. European Journal of Preventive Cardiology2017;24(Suppl 1):S69. ">Fukui 2016</a>; <a href="./references#CD011285-bbs2-0030" title="GerhardtF , DumitrescuD , GartnerC , BeccardR , ViethenT , KramerT , et al. Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study. Heart2017;103(8):592-8. NCT01763112. Training with whole body vibration in patients with PAH (GALILEO-PAH). clinicaltrials.gov/ct2/show/NCT01763112 (first received 8 January 2013). ">Gerhardt 2017</a>; <a href="./references#CD011285-bbs2-0031" title="GrunigE , EhlkenN , GhofraniA , StaehlerG , MeyerFJ , JuengerJ , et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration2011;81(5):394-401. ">Grunig 2011</a>; <a href="./references#CD011285-bbs2-0032" title="GrunigE , MaierF , EhlkenN , FischerC , LichtblauM , BlankN , et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Research and Therapy2012;14(3):R148. MaierF , GruenigE , EhlkenN , FischerC , LichtblauM , BlankN , et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. ESC Congress; 2012 25-29 August; Munich, Germany. ">Grunig 2012</a>; <a href="./references#CD011285-bbs2-0033" title="IliutaL . Effects of cardiac rehabilitation as independent predictor for favourable long term postoperative evolution in patients undergoing coronary artery bypass grafting. European Heart Journal2019;40(Issue Suppl 1):ehz747.0244. [DOI: 10.1093/eurheartj/ehz747.0244]">Iliuta 2019</a>; <a href="./references#CD011285-bbs2-0034" title="jRCT1030210240. Examination of safety and efficacy of pulmonary rehabilitation for patients with pulmonary hypertension: appropriate exercise prescription on pulmonary hypertension during exercise. rctportal.niph.go.jp/en/detail?trial_id=jRCT1030210240 (first received 13 August 2021). ">jRCT1030210240</a>; <a href="./references#CD011285-bbs2-0035" title="KabitzHJ , BremerHC , SchwoererA , SonntagF , WalterspacherS , WalkerDJ , et al. The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension. Lung2014;192(2):321-8. ">Kabitz 2014</a>; <a href="./references#CD011285-bbs2-0036" title="KahramanBO , SavciS , OzsoyI , BaranA , AcarS , OzpelitE , et al. Effects of neuromuscular electrical stimulation in patients with pulmonary arterial hypertension: a randomized controlled pilot study. Journal of Cardiology2020;75:564-71. ">Kahraman 2020</a>; <a href="./references#CD011285-bbs2-0037" title="KarapolatH , ÇınarME , TanıgörG , NalbantgilS , KayıkçıoğluM , MoğulkoçN , et al. Effects of cardiopulmonary rehabilitation on pulmonary arterial hypertension: a prospective, randomized study. Turkish Journal of Physical Medicine and Rehabilitation2019;65(3):278-86. ">Karapolat 2019</a>; <a href="./references#CD011285-bbs2-0038" title="KolesnikovaE , ArutyunovG , RylovaA , RylovaN . Respiratory muscle trainings started in acute period of complicated myocardial infarction in patients with pulmonary hypertension. Circulation2011;124(21):16976. ">Kolesnikova 2011a</a>; <a href="./references#CD011285-bbs2-0039" title="KolesnikovaEA , ArutyunovGP , RylovaNV , RylovaAK . Rehabilitation of patients with severe heart failure and pulmonary hypertension. EuroPRevent; 2011 Apr 14-16; Geneva, Switzerland. ">Kolesnikova 2011b</a>; <a href="./references#CD011285-bbs2-0040" title="MackenzieA , FordJ , JayasekeraG , PollokV , CroweT , PeacockA , et al. The role of exercise therapy in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine2017;195:A3099. [DOI: 10.1164/ajrccm-conference.2017.B28]MacKenzieA , IrvineV , McCaughyP , JayasekeraG , FordJ , KennedyF , et al. Efficacy and feasibility of pulmonary hypertension specific exercise rehabilitation in a UK setting. Thorax2018;73(Suppl 4):A74-5. McGettrickM , JayasekeraG , BrewisM , ChurchC , JohnsonM , MackenzieA . The effect of exercise rehabilitation on cardiac function, measured by cardiac MRI, in patients with pre-capillary pulmonary hypertension. European Respiratory Journal2019;54(Suppl 63):PA3946. NCT02961023. The effect of adding exercise training to optimal therapy in PAH. Clinicaltrials.gov/show/NCT02961023 (first received 10 November 2016). ">Mackenzie 2017</a>; <a href="./references#CD011285-bbs2-0041" title="MarvisiM , HerthFJ , LeyS , PolettiV , ChavannesNH , SpruitMA , et al. Selected clinical highlights from the 2012 ERS congress in Vienna. European Respiratory Journal2013;41(5):1219-27. ">Marvisi 2013</a>; <a href="./references#CD011285-bbs2-0042" title="MissanaA , AzzoliniJM , BaudouyD , SanfiorenzoC , LeroyS , SermesantM , et al. Rehabilitation in pulmonary arterial hypertension: REHAB-HTP. European Heart Journal Cardiovascular Imaging2020;21(Suppl 1):i875. ">Missana 2020</a>; <a href="./references#CD011285-bbs2-0043" title="MorrisZV , ChinLM , ChanC , GuccioneAA , AhmadA , KeyserRE . Cardiopulmonary exercise test indices of respiratory buffering before and after aerobic exercise training in women with pulmonary hypertension: differentiation by magnitudes of change in six-minute walk test performance. Respiratory Medicine2020;164:105900. ">Morris 2020</a>; <a href="./references#CD011285-bbs2-0044" title="NagelC , PrangeF , GuthS , HerbJ , EhlkenN , FischerC , et al. Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLOS One2012;7(7):e41603. PrangeF , GuthS , EhlkenN , ReichenbergerF , HalankM , KabitzHJ , et al. Exercise training improved exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. European Respiratory Society 22nd Annual Congress; 2012 Sep 1-5; Vienna, Austria. ">Nagel 2012</a>; <a href="./references#CD011285-bbs2-0045" title="NCT03186092. Effects of training in pulmonary hypertension [Effects of respiratory muscle training on respiratory muscle strength, functional capacity and quality of life in pulmonary hypertension]. clinicaltrials.gov/show/nct03186092 (first received 14 June 2017). ">NCT03186092</a>; <a href="./references#CD011285-bbs2-0046" title="NCT03476629. Effects of different types of physical training in patients with pulmonary arterial hypertension (PAH) [Effects of combined training versus aerobic training versus respiratory muscle training in patients with pulmonary hypertension: a randomized, controlled clinical trial]. clinicaltrials.gov/ct2/show/NCT03476629 (first received 26 March 2018). ">NCT03476629</a>; <a href="./references#CD011285-bbs2-0047" title="NCT04254289. Pilot randomized trial of ambulatory exercise in pulmonary hypertension (PaRTAkE-PH) [Pilot randomized trial of ambulatory exercise in pulmonary hypertension]. clinicaltrials.gov/ct2/show/NCT04254289 (first received 5 February 2020). ">NCT04254289</a>; <a href="./references#CD011285-bbs2-0048" title="NCT04559516. Remote exercise program delivery using a mobile application for pulmonary arterial hypertension (REVAMP). www.clinicaltrials.gov/ct2/show/NCT04559516 (first received 23 September 2020). ">NCT04559516</a>; <a href="./references#CD011285-bbs2-0049" title="NCT04683822. Telerehabilitation in patients with pulmonary hypertension [Investigation of the effectiveness of a home exercise program combined with telerehabilitation in pulmonary hypertension patients]. clinicaltrials.gov/ct2/show/NCT04683822 (first received 24 December 2020). ">NCT04683822</a>; <a href="./references#CD011285-bbs2-0050" title="OntiyueloM , Anna Rodó PinC , BlancoI , BlascoH , Molina FerragutL , PiccariL , et al. Evolution of patients with pulmonary arterial hypertension (PAH) six months after an exercise training program. European Respiratory Journal2019;54(Suppl 63):PA4753. ">Ontiyuelo 2019</a>; <a href="./references#CD011285-bbs2-0051" title="Robalo CordeiroC , SinghS , HerthFJ , LeyS , ChavannesNH , CliniE , et al. Selected clinical highlights from the 2010 ERS Congress in Barcelona. European Respiratory Journal2011;38(1):209-17. ">Robalo Cordeiro 2011</a>; <a href="./references#CD011285-bbs2-0052" title="RokachA , RomemA , ArishN , AzulaiH , ChenC , BertischM , et al. The effect of pulmonary rehabilitation on non-chronic obstructive pulmonary disease patients. Israel Medical Association Journal2019;21:326-9. ">Rokach 2019</a>; <a href="./references#CD011285-bbs2-0053" title="SkibarkienėJ , MilinavičienėE , KubiliusR . The effectiveness of the second stage rehabilitation of patients who implanted cardiac pacemaker. 21st European Congress of Physical and Rehabilitation Medicine (ESPRM 2018); 2018 May 1-6; Vilnius, Lithuania. [hdl.handle.net/20.500.12512/21072]">Skibarkienė 2019</a>; <a href="./references#CD011285-bbs2-0054" title="TranD , MunozP , LauE , AlisonJ , BrownM , ZhengY , et al. Inspiratory muscle training improves six-minute walk distance in adults with pulmonary arterial hypertension . Journal of the American College of Cardiology2020;75(11):2085. TranD , MunozP , LauEM , AlisonJA , BrownM , ZhengY , et al. Inspiratory muscle training improves inspiratory muscle strength and functional exercise capacity in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a pilot randomised controlled study. Heart, Lung and Circulation2021;30(3):388-95. ">Tran 2020</a>; <a href="./references#CD011285-bbs2-0055" title="CamciogluB , GucluMB , KelesMN , TacoyGA , CengelA . Effects of upper extremity aerobic exercise training on functional exercise capacity, respiratory muscle strength and dyspnea in patients with pulmonary arterial hypertension: a preliminary report. European Respiratory Journal2017;50(Suppl 61):PA2540. CamciogluB , GucluMB , KelesMN , TacoyGA , CengelA . Upper extremity aerobic exercise training improves peak oxygen consumption in patients with pulmonary arterial hypertension. European Respiratory Journal2018;52(Suppl 62):PA1442. NCT02371733. Aerobic exercise training in pulmonary arterial hypertension [Effects of upper extremity aerobic exercise training on functional exercise capacity in patients with pulmonary arterial hypertension]. clinicaltrials.gov/ct2/show/NCT02371733 (first received 26 February 2022). YılmazBC , GüçlüMB , KeleşMN , TaçoyGA , ÇengelA . Effects of upper extremity aerobic exercise training on oxygen consumption, exercise capacity, dyspnea and quality of life in patients with pulmonary arterial hypertension. Heart and Lung2020;49(5):564-71. ">Yilmaz 2020</a>; see <a href="./references#CD011285-sec-0098" title="">Characteristics of excluded studies</a> table). Common reasons for excluding studies were not being RCTs, no specific exercise training such as aerobic or strength training, or an ineligible study population. </p> </section> <section id="CD011285-sec-0045"> <h4 class="title">Studies awaiting classification</h4> <p>Eleven studies are awaiting classification (<a href="./references#CD011285-bbs2-0056" title="NCT00477724. Incidence of latent pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension after endarterectomy and influence of exercise and respiratory therapy. clinicaltrials.gov/show/NCT00477724 (first received 24 May 2007). ">NCT00477724</a>; <a href="./references#CD011285-bbs2-0057" title="NCT00491309. Exercise and respiratory therapy in patients with rheumatoid arthritis / collagenosis and pulmonary hypertension. clinicaltrials.gov/ct2/show/NCT00491309 (first received 26 June 2007). ">NCT00491309</a>; <a href="./references#CD011285-bbs2-0058" title="NCT02558582. Effect of exercise training in patients with pulmonary hypertension [Effect of exercise training in arterial and chronic thromboembolic pulmonary hypertension in Switzerland and standardization with European countries]. clinicaltrials.gov/ct2/show/nct02558582 (first received 24 September 2015). ">NCT02558582</a>; <a href="./references#CD011285-bbs2-0059" title="NCT02579954. Cardiac function and exercise capacity in pulmonary arterial hypertension (FONCE-HTAP). clinicaltrials.gov/ct2/show/nct02579954 (first received 20 October 2015). ">NCT02579954</a>; <a href="./references#CD011285-bbs2-0060" title="NCT03045666. Impact of rehabilitation program on PAH patients treated with macitentan. clinicaltrials.gov/ct2/show/NCT03045666 (first received 7 February 2017). ">NCT03045666</a>; <a href="./references#CD011285-bbs2-0061" title="NCT03288025. Pulmonary arterial hypertension improvement with nutrition and exercise (PHINE) [Pulmonary arterial hypertension improvement with nutrition and exercise (PHINE): a randomized controlled trial]. clinicaltrials.gov/ct2/show/NCT03288025 (first received 19 September 2017). ">NCT03288025</a>; <a href="./references#CD011285-bbs2-0062" title="NCT03955016. Rehabilitation for patients with pulmonary hypertension [A randomized controlled trial to evaluate the effect of a rehabilitation program on the exercise capacity of patients with pulmonary hypertension]. clinicaltrials.gov/ct2/show/nct03955016 (first received 17 May 2019). ">NCT03955016</a>; <a href="./references#CD011285-bbs2-0063" title="NCT4188756. RV systolic and diastolic function and contractile reserve under acute exercise and in response to chronic exercise-based rehabilitation (Reserve). clinicaltrials.gov/show/NCT04188756 (first received 6 December 2019). ">NCT04188756</a>; <a href="./references#CD011285-bbs2-0064" title="NCT04224012. Effect of exercise and respiratory therapy on right ventricular function in severe pulmonary hypertension. clinicaltrials.gov/show/NCT04224012 (first received 13 January 2020. ">NCT04224012</a>; <a href="./references#CD011285-bbs2-0065" title="NCT04909008. Exercise training to improve cardiopulmonary hemodynamics in heart failure patients [Exercise training to improve pulmonary haemodynamic and right ventricular function in heart failure patients with pulmonary hypertension]. clinicaltrials.gov/show/NCT04909008 (first received 1 June 2021). ">NCT04909008</a>; <a href="./references#CD011285-bbs2-0066" title="NCT05242380. Exercise training in patients with pulmonary arterial hypertension [The effects of kettlebell exercise training in patients with pulmonary arterial hypertension]. ClinicalTrials.gov/show/NCT05242380 (first received 16 February 2022). ">NCT05242380</a>; see <a href="./references#CD011285-sec-0099" title="">Characteristics of studies awaiting classification</a> table). </p> </section> <section id="CD011285-sec-0046"> <h4 class="title">Ongoing studies</h4> <p>Two studies are ongoing (<a href="./references#CD011285-bbs2-0067" title="ISRCTN10608766. Supervised pulmonary hypertension exercise rehabilitation (sphere) trial [Supervised pulmonary hypertension exercise rehabilitation (SPHERe): a multi-centre randomized controlled trial]. www.isrctn.com/ISRCTNISRCTN10608766 (first received 13 March 2019). McGregorG , BruceJ , EnnisS , MasonJ , LallR , JiC , et al. Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial. BMC Pulmonary Medicine2020;20(1):143. [DOI: 10.1186/s12890-020-01182-y]">McGregor 2020</a>; <a href="./references#CD011285-bbs2-0068" title="ACTRN12616001467426. Exercise training in pulmonary hypertension [Exercise training in pulmonary hypertension (ExTra_PH): a randomised controlled trial examining short and long-term outcomes of an outpatient-based exercise training in pulmonary hypertension]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12616001467426 (first received 21 October 2016). MorrisNR , LouisM , StrugnellW , HarrisJ , LinA , FeenstraJ , et al. Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH). BMC Pulmonary Medicine2018;18(1):40. [DOI: 10.1186/s12890-018-0586-8]">Morris 2018</a>; see <a href="./references#CD011285-sec-0100" title="">Characteristics of ongoing studies</a> table). </p> </section> </section> <section id="CD011285-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>Details on our judgements on the potential risks of bias are summarised in <a href="#CD011285-fig-0002">Figure 2</a> and <a href="#CD011285-fig-0003">Figure 3</a>, with full details in the <a href="./references#CD011285-sec-0097" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD011285-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011285-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011285-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011285-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011285-sec-0048"> <h4 class="title">Allocation</h4> <p>Ten studies provided details on how the randomisation sequence was generated, and we judged them at low risk (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). For the remaining studies we were unable to ascertain details of random sequence generation (unclear risk of bias). </p> <p>None of the studies provided details on how allocation was concealed, and were at unclear risk of bias in this domain. </p> </section> <section id="CD011285-sec-0049"> <h4 class="title">Blinding</h4> <p>Given the nature of the intervention (exercise training) it was not possible to blind participants or personnel to the intervention. Therefore, all studies were at high risk of bias for blinding of participants and personnel. Ten studies reported blinding of outcome assessors and were at low risk of detection bias (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>). The remaining studies were at unclear risk of detection bias. </p> </section> <section id="CD011285-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>Six studies were at low risk of attrition bias with each of these studies reporting no or very small numbers of dropouts (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). The two largest studies (195 participants in total) were at high risk of attrition bias with each reporting a greater number of dropouts in the intervention group (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>: 17% dropout in the intervention group versus 0% in the control; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>: 15% dropout in the intervention group versus 5% in the control). The six remaining studies were also at high risk of attrition bias due to a high number of withdrawals, or unbalanced withdrawal rates between groups, or both (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). </p> </section> <section id="CD011285-sec-0051"> <h4 class="title">Selective reporting</h4> <p>Five studies were at low risk of reporting bias (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). Six studies did not provide complete results when compared to those provided on the trial registry and were at high risk of bias (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). Of the outcome measures not reported only <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a> did not report outcomes that would have affected this review, namely changes in Functional Class and brain natriuretic peptide (BNP). However, we did not extract any data from this study as it did not report any control data. The remaining studies provided insufficient details to ascertain reporting bias and were at unclear risk (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). </p> </section> <section id="CD011285-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>Six studies were at low risk with regard to other sources of bias (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). We were unable to rule out possible selection bias in five studies (unclear risk) (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). Neither <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a> nor <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a> provided a CONSORT diagram and hence there were no details of how many participants they screened to achieve the enrolment target (high risk) (<a href="./references#CD011285-bbs2-0111" title="SchulzKF , AltmanDG , MoherD , for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Annals of Internal Medicine2010;152(11):726-32.">Schulz 2010</a>). <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>, whilst providing a CONSORT diagram, provided no details on how many participants were screened and how they applied the inclusion/exclusion criteria to achieve the target enrolment of 95 participants (high risk). </p> </section> </section> <section id="CD011285-sec-0053"> <h3 class="title" id="CD011285-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD011285-tbl-0001"><b>Summary of findings 1</b> Exercise compared to control for pulmonary hypertension</a> </p> <p>The 14 RCTs included in this review compared exercise‐based rehabilitation to no intervention, education alone or usual care (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). We used data extracted from published journal articles or, in one instance, a published PhD thesis (<a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>). Three studies did not contribute to the data synthesis (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). We were unable to extract primary or secondary outcome data from <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a> (published only as an abstract) despite attempts to contact the study authors. Similarly, we were unable to extract data for synthesis from <a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>. Whilst the authors reported changes in exercise capacity (VO<sub>2peak</sub>), the magnitude of change could not be ascertained. Attempts to contact the author and clarify the magnitude of change were unsuccessful. Finally, <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a> did not present control group data for comparison as all control participant data were lost to follow‐up due to the impact of coronavirus‐19 (COVID‐19) on measurement of trial outcomes. </p> <p>Hence, comparisons between exercise‐based rehabilitation and control used data from 11 studies. See <a href="./full#CD011285-tbl-0001">summary of findings Table 1</a> for the main comparisons between the intervention and control groups. In total, there were 21 outcomes evaluated including primary outcomes of exercise capacity, serious adverse events and HRQoL. </p> <section id="CD011285-sec-0054"> <h4 class="title">Primary outcomes</h4> <section id="CD011285-sec-0055"> <h5 class="title">Exercise capacity: six‐minute walk distance</h5> <p>Eleven studies reported changes in 6MWD (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). There was a change in 6MWD in 211 participants who completed the exercise‐based rehabilitation intervention and 207 participants who acted as a control. Exercise training may result in a large increase in 6MWD compared to control, with the lower end of the CI exceeding the minimal important difference of 30 metres (MD 48.52 metres, 95% CI 33.42 to 63.62; I² = 72%; 11 studies, 418 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0005" title="">Analysis 1.1</a>) (<a href="./references#CD011285-bbs2-0091" title="HollandAE , SpruitMA , TroostersT , PuhanMA , PepinV , SaeyD , et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. European Respiratory Journal2014;44(6):1428-46.">Holland 2014</a>; <a href="./references#CD011285-bbs2-0096" title="MathaiSC , PuhanMA , LamD , WiseRA . The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine2012;185(5):428-33.">Mathai 2012</a>). </p> <p>We also examined the responses by different subgroups of PH using the classification outlined by <a href="./references#CD011285-bbs2-0089" title="HoeperMM , BogaardHJ , CondliffeR , FrantzR , KhannaD , KurzynaM , et al. Definitions and diagnosis of pulmonary hypertension. Journal of the American College of Cardiology2013;62(25 Suppl):D42-50.">Hoeper 2013</a>. Eight studies included a mixed group of participants with PH, including both those with PAH (i.e. those from Group I, <a href="./references#CD011285-bbs2-0089" title="HoeperMM , BogaardHJ , CondliffeR , FrantzR , KhannaD , KurzynaM , et al. Definitions and diagnosis of pulmonary hypertension. Journal of the American College of Cardiology2013;62(25 Suppl):D42-50.">Hoeper 2013</a>) and CTEPH (i.e. Group 4, <a href="./references#CD011285-bbs2-0089" title="HoeperMM , BogaardHJ , CondliffeR , FrantzR , KhannaD , KurzynaM , et al. Definitions and diagnosis of pulmonary hypertension. Journal of the American College of Cardiology2013;62(25 Suppl):D42-50.">Hoeper 2013</a>) (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). We were unable to extract data separately for the subgroups in these studies. We performed a subgroup analysis for three studies that only included participants with PAH (Group 1) comparing with those of mixed PH (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). For the PAH group, the mean increase in 6MWD favoured exercise‐based rehabilitation and exceeded the minimal important difference (MD 63.97 metres, 95% CI 8.74 to 119.21; I² = 75%; 3 studies, 71 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0005" title="">Analysis 1.1</a>), and was not different from the mixed PH group (MD 44.16 metres, 95% CI 28.97 to 59.36; I² = 72%; 8 studies, 347 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0005" title="">Analysis 1.1</a>; test for subgroup differences: Chi² = 0.46, degrees of freedom (df) = 1 (P = 0.50), I² = 0%). </p> <p>Given the substantial heterogeneity in the change in 6MWD with exercise‐based rehabilitation across studies (I² = 72%), we explored a possible source using a post hoc analysis evaluating the setting for exercise‐based rehabilitation comparing inpatient‐based (four studies; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>) versus outpatient‐based (seven studies; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>) programmes. We hypothesised that differences in exercise‐based rehabilitation setting may account for some heterogeneity, as inpatient programmes allowed for closer supervision, a greater intensity of exercise prescription and hence a greater improvement in exercise capacity. Studies that included inpatient‐based exercise rehabilitation (61% of the sample) reported improvements in 6MWD favouring exercise‐based rehabilitation; however, the increase in 6MWD remained heterogeneous across studies (MD 59.39 metres, 95% CI 29.95 to 88.82; I² = 77%; 4 studies, 245 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0006" title="">Analysis 1.2</a>). Outpatient‐based programmes also favoured exercise‐based rehabilitation, with a heterogeneous response (MD 43.21 metres, 95% CI 23.84 to 62.57; I² = 72%; 7 studies, 173 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0006" title="">Analysis 1.2</a>). There was no difference in inpatient and outpatient programmes for change in 6MWD (<a href="./references#CD011285-fig-0006" title="">Analysis 1.2</a>; test for subgroup differences: Chi² = 0.81, df = 1 (P = 0.37), I² = 0%). </p> <p>As we had more than 10 trials for the 6MWT outcome measure we generated a funnel plot of all the 6MWT data (<a href="#CD011285-fig-0004">Figure 4</a>). On inspection, there appears to be asymmetry in the funnel plot, with a lack of smaller studies with minimal or no effect on 6MWD. This would suggest there may be publication bias with fewer smaller, negative or small effect studies being reported. </p> <div class="figure" id="CD011285-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Figure 4. Funnel plot comparison: exercise intervention versus usual care for change in six‐minute walk distance following exercise‐based rehabilitation." data-id="CD011285-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Figure 4. Funnel plot comparison: exercise intervention versus usual care for change in six‐minute walk distance following exercise‐based rehabilitation. </p> </div> </div> </div> </section> <section id="CD011285-sec-0056"> <h5 class="title">Exercise capacity: cardiopulmonary exercise test</h5> <p>Seven studies reported changes in peak exercise capacity measured using CPET (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). Exercise training may increase VO<sub>2peak</sub> and peak power compared to control (VO<sub>2peak</sub>: MD 2.07 mL/kg/min, 95% CI 1.57 to 2.57; I² = 62%; 7 studies, 314 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0007" title="">Analysis 1.3</a>; peak power: MD 9.69 W, 95% CI 5.52 to 13.85; I² = 71%; 5 studies, 226 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0009" title="">Analysis 1.5</a>). There is no reported minimal important difference for CPET‐derived measures of exercise capacity in PH. Three studies reported changes in the anaerobic threshold, one of which was reported as time to anaerobic threshold (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>), whilst the other two reported this in millilitres per minute (<a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). The increase in the anaerobic threshold favoured the exercise rehabilitation group (SMD 1.05, 95% CI 0.53 to 1.58; I² = 0%; 3 studies, 66 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0011" title="">Analysis 1.7</a>). </p> <p>Subgroup analysis for participants with PAH found no evidence of a difference between groups in VO<sub>2peak</sub> (MD 1.27 mL/kg/min, 95% CI −0.21 to 2.76; I² = 0%; 2 studies, 36 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0007" title="">Analysis 1.3</a>). For the mixed PH group there was a change in VO<sub>2peak</sub> favouring the exercise rehabilitation group but there was substantial heterogeneity (MD 2.17 mL/kg/min, 95% CI 1.64 to 2.70; I² = 72%; 5 studies, 278 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0007" title="">Analysis 1.3</a>). However, there was no evidence of a difference between the PAH and PH groups (test for subgroup differences: Chi² = 1.24, df = 1 (P = 0.27), I² = 19.5%; <a href="./references#CD011285-fig-0007" title="">Analysis 1.3</a>). There was an increase in W<sub>peak</sub> for the both the PAH and the mixed PH subgroup favouring exercise‐based rehabilitation (PAH: MD 14.24 W, 95% CI 5.78 to 22.70; I² = 0%; 2 studies, 36 participants; low‐certainty evidence; mixed PH: MD 8.22 W, 95% CI 3.43 to 13.01; I² = 84%; 3 studies, 190 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0009" title="">Analysis 1.5</a>); however, the response for the mixed PH group was heterogeneous. There was no evidence of a difference between the PAH and PH groups (test for subgroup differences: Chi² = 1.47, df = 1 (P = 0.23), I² = 32.0%; <a href="./references#CD011285-fig-0009" title="">Analysis 1.5</a>). </p> <p>We examined the heterogeneity related to the setting for exercise‐based rehabilitation by examining the rehabilitation setting. Studies that included an inpatient‐based exercise rehabilitation programmes reported an increase in VO<sub>2peak</sub> favouring exercise‐based rehabilitation, but the response remained heterogeneous (MD 2.00 mL/kg/min, 95% CI 1.36 to 2.64; I² = 83%; 3 studies, 217 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0008" title="">Analysis 1.4</a>) (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). Studies of outpatient‐based programmes reported a similar increase in VO<sub>2peak</sub> favouring exercise‐based rehabilitation (MD 2.18 mL/kg/min, 95% CI 1.38 to 2.98; I² = 21%; 4 studies, 97 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0008" title="">Analysis 1.4</a>) (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>). There was no evidence of a difference in the change in VO<sub>2peak</sub> between settings (test for subgroup differences: Chi² = 0.12, df = 1 (P = 0.73), I² = 0%; <a href="./references#CD011285-fig-0008" title="">Analysis 1.4</a>). The changes in W<sub>peak</sub> for participants that included an inpatient programme or were solely based in an outpatient/home programme are shown in <a href="./references#CD011285-fig-0010" title="">Analysis 1.6</a>. For both settings, the increase favoured exercise‐based rehabilitation and there was no difference in the change in W<sub>peak</sub> between settings (test for subgroup differences: Chi² = 1.47, df = 1 (P = 0.23), I² = 32%). The response remained heterogeneous for the inpatient group (I² = 84%), whereas the result was consistent for the outpatient group (I² = 0%). </p> <p>Overall the certainty of evidence for changes in exercise capacity was low due to lack of allocation concealment, incomplete outcome data reporting and inconsistency. For details, see <a href="./full#CD011285-tbl-0001">summary of findings Table 1</a>. </p> </section> <section id="CD011285-sec-0057"> <h5 class="title">Serious adverse events</h5> <p>Eleven studies provided details on serious adverse events (see <a href="#CD011285-sec-0021">Primary outcomes</a>). Meta‐analysis demonstrated that there was no increased risk of serious adverse events with exercise‐based rehabilitation compared to usual care (RD 0, 95% CI −0.03 to 0.03; I² = 0%; 11 studies, 439 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0012" title="">Analysis 1.8</a>). In total, there were five serious adverse events reported across the 11 studies. One study reported a participant death in the control group and no adverse events in the exercise group (<a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). Two other studies reported serious adverse events (<a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>). In their multicentred trial, <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a> reported three adverse events in the exercise group (decompensated diabetes, generalised oedema and stroke). One study reported a single participant having to stop exercise training for a single session due to extreme lightheadedness (<a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>). No other studies reported any serious adverse events (i.e. mortality, disease progression, symptoms that precluded training or discontinuation of the study). Subgroup analysis of serious adverse events for the PAH versus mixed PH groups found no evidence of a difference between groups (test for subgroup differences: Chi² = 0.13, df = 1 (P = 0.72), I² = 0%; <a href="./references#CD011285-fig-0012" title="">Analysis 1.8</a>). </p> <p>Overall the certainty of evidence for serious adverse events was moderate due to lack of allocation concealment. For details, see <a href="./full#CD011285-tbl-0001">summary of findings Table 1</a>. </p> </section> <section id="CD011285-sec-0058"> <h5 class="title">Health‐related quality of life</h5> <p>Studies reported quality of life using either the SF‐36 questionnaire (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>), or the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), a PH‐specific questionnaire (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>). One study reported changes in the quality of life using the EQ‐5D‐3L (<a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). </p> <p>We reported the changes in the Physical Component Summary (PCS) and Mental Component Summary (MCS) of the SF‐36 in <a href="./references#CD011285-fig-0013" title="">Analysis 1.9</a> and <a href="./references#CD011285-fig-0014" title="">Analysis 1.10</a>, as these provide an indication of the global improvement in both physical and emotional dimensions of quality of life measured using this tool. Five studies reported changes in PCS and MCS (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>). Analysis showed that improvements in HRQoL favoured exercise‐based interventions for PCS and MCS (PCS: MD 3.98, 95% CI 1.89 to 6.07; I² = 38%; 5 studies, 187 participants; moderate‐certainty evidence; MCS: MD 3.60, 95% CI 1.21 to 5.98; I² = 0%; 5 studies, 186 participants; moderate‐certainty evidence). Subgroup analysis for the participants with PAH demonstrated a similar improvement favouring exercise‐based rehabilitation in both the PCS and MCS (PCS: MD 4.63, 95% CI 0.80 to 8.47; I² = 0%; 2 RCTs, 33 participants; moderate‐certainty evidence; MCS: MD 4.17, 95% CI 0.01 to 8.34; I² = 0%; 2 studies, 33 participants; moderate‐certainty evidence) (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>). There was no evidence of a difference between the PAH and mixed PH subgroups for the change in PCS and MCS (PCS: test for subgroup differences: Chi² = 0.16, df = 1 (P = 0.69), I² = 0%; MCS: test for subgroup differences: Chi² = 10.11, df = 1 (P = 0.74), I² = 0%). </p> <p>Two studies examined changes in HRQoL using the CAMPHOR and reported greater improvement in the exercise‐based rehabilitation group than usual care in each of the subscores for activities, symptoms and overall quality of life (activities: MD −1.33, 95% CI −3.56 to 0.90; I² = 67%; 2 studies, 33 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0023" title="">Analysis 1.19</a>; symptoms: MD −3.08, 95% CI −7.78 to 1.62; I² = 88%; 2 studies, 36 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0024" title="">Analysis 1.20</a>; overall quality of life: MD −5.42, 95% CI −8.03 to −2.81; I² = 29%; 2 studies, 36 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0025" title="">Analysis 1.21</a>) (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>). </p> <p>Five studies reported changes in quality of life using all (or some) of the eight domains of the SF‐36 (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). Improvements favoured exercise‐based rehabilitation for SF‐36 domains of Role Physical, Mental Health, Vitality and Social Function (Role Physical: MD 20.46, 95% CI 13.77 to 27.15; I² = 0%; 5 studies, 220 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0016" title="">Analysis 1.12</a>; Mental Health: MD 6.95, 95% CI 2.12 to 11.79; I² = 42%; 4 studies, 191 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0019" title="">Analysis 1.15</a>; Vitality: MD 9.67, 95% CI 2.61 to 16.73; I² = 59%; 5 studies, 219 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0021" title="">Analysis 1.17</a>; Social Function: MD 12.20, 95% CI 7.32 to 17.08; I² = 27%; 5 studies, 222 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0022" title="">Analysis 1.18</a>). There was probably little to no difference between exercise‐based rehabilitation and usual care in the SF‐36 domains of Physical Function, Bodily Pain, General Health and Role Emotional (Physical Function: MD 5.29, 95% CI −1.15 to 11.73; I² = 33%; 5 studies, 216 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0015" title="">Analysis 1.11</a>; Bodily Pain: MD 4.17, 95% CI −2.01 to 10.36; I² = 0%; 4 studies, 192 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0017" title="">Analysis 1.13</a>; General Health: MD 2.14, 95% CI −4.45 to 8.74; I² = 45%; 4 studies, 188 participants; moderate‐certainty evidence: <a href="./references#CD011285-fig-0018" title="">Analysis 1.14</a>; Role Emotional: MD 3.16, 95% CI −4.98 to 11.30; I² = 0%; 4 studies, 191 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0020" title="">Analysis 1.16</a>). </p> <p>Overall the certainty of evidence for serious adverse events was moderate due to lack of allocation concealment and incomplete outcome data reporting. For details, see <a href="./full#CD011285-tbl-0001">summary of findings Table 1</a>. </p> </section> </section> <section id="CD011285-sec-0059"> <h4 class="title">Secondary outcomes</h4> <section id="CD011285-sec-0060"> <h5 class="title">Cardiopulmonary haemodynamics</h5> <p>Two studies reported changes in cardiopulmonary haemodynamics measured using right heart catheterisation following exercise‐based rehabilitation (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>). Using subsets of the study participants (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>: 31 exercise and 28 control; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>: 38 exercise and 36 control), there were reductions in mPAP favouring exercise training (MD −9.29, 95% CI −12.96 to −5.61; I² = 0%; 2 RCTs, 133 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0026" title="">Analysis 1.22</a>). </p> </section> <section id="CD011285-sec-0061"> <h5 class="title">Functional class</h5> <p>Two studies reported changes in Functional Class for exercise and control groups (<a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). There was an improvement in Functional Class favouring exercise rehabilitation (MD −0.46, 95% CI −0.64 to −0.28; I² = 57%; 2 studies, 40 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0027" title="">Analysis 1.23</a>). </p> </section> <section id="CD011285-sec-0062"> <h5 class="title">Clinical worsening during follow‐up period</h5> <p>There were no available data for analysis.</p> </section> <section id="CD011285-sec-0063"> <h5 class="title">Mortality during the follow‐up period</h5> <p>There were no available data for analysis.</p> </section> <section id="CD011285-sec-0064"> <h5 class="title">B‐type natriuretic peptide</h5> <p>Four studies reported changes in B‐type natriuretic peptide for exercise and control groups (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). There was no evidence of a difference between exercise‐based rehabilitation and usual care (MD −68.69, 95% CI −154.89 to 17.51; I² = 0%; 4 studies, 220 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0028" title="">Analysis 1.24</a>). </p> </section> </section> <section id="CD011285-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>For our sensitivity analysis, we removed studies that did not specify blinding of outcome measurements or had incomplete outcome data (attrition bias). As a result, we removed two studies from the analysis of exercise outcomes (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>). Sensitivity analysis did not change the pattern of findings for exercise capacity, with the exercise group showing improvements in 6MWD, VO<sub>2peak</sub> and W<sub>peak</sub> compared to control (6MWD: MD 59.56 metres, 95% CI 37.64 to 81.49; I² = 75%; 8 studies, 199 participants; low‐certainty evidence; <a href="./references#CD011285-fig-0029" title="">Analysis 1.25</a>; VO<sub>2peak</sub>: MD 2.27 mL/kg/m², 95% CI 1.53 to 3.00; I² = 4%; 8 studies, 135 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0030" title="">Analysis 1.26</a>; W<sub>peak</sub>: MD 15.27 W, 95% CI 8.57 to 21.97; I² = 0%; 3 studies, 66 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0031" title="">Analysis 1.27</a>). There were similar findings for HRQoL measured using the PCS and MCS (PCS: MD 4.61, 95% CI 1.17 to 8.05; I² = 51%; 4 studies, 88 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0032" title="">Analysis 1.28</a>; MCS: MD 4.33, 95% CI 1.41 to 7.24; I² = 8%; 4 studies, 87 participants; moderate‐certainty evidence; <a href="./references#CD011285-fig-0033" title="">Analysis 1.29</a>). </p> </section> <section id="CD011285-sec-0066"> <h4 class="title">Subgroup analysis</h4> <section id="CD011285-sec-0067"> <h5 class="title">Severity of pulmonary hypertension</h5> <p>There were insufficient data to perform subgroup analysis according to disease severity</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011285-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011285-sec-0068"></div> <section id="CD011285-sec-0069"> <h3 class="title" id="CD011285-sec-0069">Summary of main results</h3> <p>The current analysis suggests that exercise‐based rehabilitation improves exercise capacity measured using 6MWD and CPET (VO<sub>2peak</sub>, W<sub>peak</sub> and anaerobic threshold). In addition, there were clinically important improvements in quality of life, measured using both PH‐specific and generic tools. Exercise‐based rehabilitation was not associated with an increased risk of serious adverse events. </p> <p>Building from the earlier review (<a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>), which included six RCTs, the current review sourced an additional eight RCTs comparing exercise‐based rehabilitation with no exercise or usual care. In total, 11 RCTs contributed to meta‐analysis in the current review. Previously, we were unable to report on the impact of exercise‐based rehabilitation on central haemodynamics due to insufficient data (<a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>). However, the addition to the current review of the second‐largest study to date, which also measured central haemodynamics, has provided additional evidence to suggest that rather than having a negative impact on mPAP, exercise‐based rehabilitation resulted in a large and clinically important fall in mPAP when compared to control (−9.29 mmHg, 95% CI −12.96 to −5.61). Changes in B‐type natriuretic peptide were similar between groups, and we were unable to comment on changes in Functional Class due to insufficient data. Based on these studies, our analysis suggests that exercise‐based rehabilitation is safe, does not increase mPAP, and results in clinically meaningful changes in exercise capacity and quality of life. </p> </section> <section id="CD011285-sec-0070"> <h3 class="title" id="CD011285-sec-0070">Overall completeness and applicability of evidence</h3> <p>The aim of this review was to update the previous review examining the efficacy of exercise‐based rehabilitation in people with PH <a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>. The previous review identified six studies, five of which were included in the analysis (170 participants in total). This updated review identified eight additional RCTs, of which 11 were included in the data synthesis, with a total of 462 participants. Similar to our previous review (<a href="./references#CD011285-bbs2-0123" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285.pub2]">Morris 2017</a>), most participants in the studies had a diagnosis of PAH, so our results should be applied primarily in that group. There were a few participants with CTEPH; however, their results could not be extracted separately, so it is difficult to be confident regarding the effects of exercise rehabilitation in this group. Of the studies completed to date, none have included groups of participants who had PH associated with connective tissue disease, PH due to left heart disease or PH due to lung disease, so our results cannot be applied to these groups. One study examined the effect of exercise‐based rehabilitation on participants with uncorrected atrial septal defect‐associated PH (<a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). Few participants in Functional Class IV were included, so the impact of exercise rehabilitation in those with the most severe disease remains unclear. Importantly, all studies only included participants who were stable on medical therapy (including no recent syncope), so it is in this group that the results of this review on exercise‐based rehabilitation can be applied. </p> <p>Whilst there were significant improvements in exercise capacity measured using 6MWD and CPET, there was substantial variation across studies. We were unable to determine whether this was due to the differences in study populations (PAH versus other), the severity of the disease (where there was insufficient evidence to assess) or the rehabilitation setting. Five of 11 studies that reported changes in exercise capacity used an inpatient rehabilitation programme of at least three weeks in duration, with exercise training taking place seven days per week (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). There was no evidence of a difference between inpatient‐based and outpatient‐based exercise programmes that reported changes in exercise capacity (P = 0.06). </p> <p>The exercise rehabilitation protocols tested included lower limb endurance training (walking or cycling), usually with resistance exercises for the upper and lower limbs. These protocols are similar to those recommended for standard pulmonary (<a href="./references#CD011285-bbs2-0113" title="SpruitMA , SinghSJ , GarveyC , ZuWallackR , NiciL , RochesterC , et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine2013;188(8):e13-64.">Spruit 2013</a>) and cardiac (<a href="./references#CD011285-bbs2-0102" title="PiepoliMF , CorràU , AdamopoulosS , BenzerW , Bjarnason-WehrensB , CupplesM , et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention and Rehabilitation. European Journal Preventative Cardiology2014;21:664-81.">Piepoli 2014</a>) rehabilitation programmes. Additional components in some studies included stretching, breathing techniques such as pursed lip breathing, body perception, yoga and respiratory muscle training (<a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). No study examined the impact of strength training alone with most exercise protocols blending both aerobic (endurance) and strength training. Further data are required to identify the contribution of aerobic and strength training alone and of the additional components to rehabilitation outcomes. The similarity of the core rehabilitation components to those delivered in pulmonary and cardiac rehabilitation programmes (lower limb endurance training, upper and lower limb resistance training) suggests that people with PH could receive their rehabilitation within these existing services, which could improve uptake into practise. However, some studies in this review used specialised exercise prescription and monitoring practises that may not occur routinely in existing cardiopulmonary rehabilitation programmes (e.g. low‐intensity interval training, continuous monitoring of oxyhaemoglobin saturation and heart rate, restriction of exercise heart rate to less than 120 beats per minute) (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>). </p> <p>Whilst there were a total of five serious adverse events reported across 11 studies (415 participants), analysis found that exercise‐based rehabilitation was not associated with an increased risk of serious adverse events. However, it should be noted that studies did not apply a universal definition for adverse events. Whilst some provided a clear definition for the type of adverse events being detected (<a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>), others provided no details (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>), and merely noted that adverse events would be reported. It is worth noting that exercise is not entirely without risk in people with PH (<a href="./references#CD011285-bbs2-0097" title="MorrisNR , SealeH , HarrisJ , HallK , HopkinsP , KermeenF . Serious adverse events during a 6-min walk test in patients with pulmonary hypertension. European Respiratory Journal2015;45(4):1179-82.">Morris 2015</a>), and international guidelines currently suggest that exercise rehabilitation should be undertaken "… by centres experienced in both PH patient care and rehabilitation of compromised patients" (<a href="./references#CD011285-bbs2-0083" title="GalièN , HumbertM , VachieryJL , GibbsS , LangI , TorbickiA . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Respiratory Journal2015;46(4):903-75.">Galie 2015</a>). </p> <p>We found two studies that are currently ongoing. One study is examining the role of exercise‐based rehabilitation in an outpatient setting (<a href="./references#CD011285-bbs2-0068" title="ACTRN12616001467426. Exercise training in pulmonary hypertension [Exercise training in pulmonary hypertension (ExTra_PH): a randomised controlled trial examining short and long-term outcomes of an outpatient-based exercise training in pulmonary hypertension]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12616001467426 (first received 21 October 2016). MorrisNR , LouisM , StrugnellW , HarrisJ , LinA , FeenstraJ , et al. Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH). BMC Pulmonary Medicine2018;18(1):40. [DOI: 10.1186/s12890-018-0586-8]">Morris 2018</a>), whilst the other implemented a supervised home‐based programme (<a href="./references#CD011285-bbs2-0067" title="ISRCTN10608766. Supervised pulmonary hypertension exercise rehabilitation (sphere) trial [Supervised pulmonary hypertension exercise rehabilitation (SPHERe): a multi-centre randomized controlled trial]. www.isrctn.com/ISRCTNISRCTN10608766 (first received 13 March 2019). McGregorG , BruceJ , EnnisS , MasonJ , LallR , JiC , et al. Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial. BMC Pulmonary Medicine2020;20(1):143. [DOI: 10.1186/s12890-020-01182-y]">McGregor 2020</a>). The results of these studies are pending. </p> </section> <section id="CD011285-sec-0071"> <h3 class="title" id="CD011285-sec-0071">Quality of the evidence</h3> <p>We were able to extract data from 11 of 14 studies all of which were published articles enabling us to report on a range of outcome measures. However, several sources of bias remained. No studies provided details on how allocation was concealed; however, 10 of 14 studies reported details on how they generated randomisation sequence. Like most exercise‐based rehabilitation interventions it was impossible to blind participants to the group allocation. Offsetting this somewhat was the fact that 10 studies noted that outcome assessors were blinded to group allocation, which is important for rehabilitation studies where many of the important outcomes (exercise capacity, HRQoL) could be affected by knowledge of group assignment. </p> <p>Using GRADE, the outcomes provided low‐ to moderate‐certainty evidence. Review outcomes rated with moderate certainty included HRQoL and adverse events. Low‐certainty evidence included our primary outcome of exercise capacity (6MWD, VO<sub>2peak</sub> and W<sub>peak</sub>). The risk of bias was increased due to attrition bias, particularly in two of the largest studies completed to date (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>). Moreover, the changes in exercise capacity were heterogeneous and, whilst we explored this uncertainty by comparing the site of exercise‐based rehabilitation (inpatient versus outpatient), other factors must still be contributing to this heterogeneity. </p> </section> <section id="CD011285-sec-0072"> <h3 class="title" id="CD011285-sec-0072">Potential biases in the review process</h3> <p>Two review authors independently extracted all data using Covidence and resolved discrepancies through discussion (<a href="./references#CD011285-bbs2-0076" title="Covidence. Version accessed prior to 8 November 2022. Melbourne, Australia: Veritas Health Innovation. Available at www.covidence.org.">Covidence</a>). Two review authors also independently assessed risk of bias. We included studies that were published only in abstract form to ensure that we included all available trials. However, despite attempts to contact the study authors, three studies did not contribute data that could be included in meta‐analysis (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). This may have influenced assessment of trial quality and some estimates of effect. </p> <p>We included a post‐hoc subgroup analysis (inpatient versus outpatient rehabilitation setting) that was not included in our original protocol (<a href="./references#CD011285-bbs2-0122" title="MorrisNR , KermeenFD , HollandAE . Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database of Systematic Reviews2014, Issue 10. Art. No: CD011285. [DOI: 10.1002/14651858.CD011285]">Morris 2014</a>). This was because the marked heterogeneity in exercise outcomes prompted us to further explore the differences between studies, but substantial heterogeneity remained. Moreover, we acknowledge that it is difficult to draw firm conclusions from this analysis due the post‐hoc nature of the approach. Another factor that could have contributed to the heterogeneity of results could have been related to the advances in pharmacological therapy for PH over time, which may have in turn impacted on the responses to exercise‐based rehabilitation. Unfortunately, we were unable to examine the effects of these advances in therapy, as specific pharmacological management was infrequently reported. </p> </section> <section id="CD011285-sec-0073"> <h3 class="title" id="CD011285-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>Several systematic reviews on exercise training in PH have been published to date (<a href="./references#CD011285-bbs2-0069" title="AlbanaqiAL , RahimiGR , SmartNA . Exercise training for pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Biological Research for Nursing2021;12:2691-705.">Albanaqi 2021</a>; <a href="./references#CD011285-bbs2-0071" title="BabuAS , PadmakumarR , MaiyaAG , MohapatraAK , KamathRL . Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials. Heart, Lung and Circulation2016;25(4):333-41.">Babu 2016a</a>; <a href="./references#CD011285-bbs2-0073" title="BuysR , AvilaA , CornelissenVA . Exercise training improves physical fitness in patients with pulmonary arterial hypertension: a systematic review and meta-analysis of controlled trials. BMC Pulmonary Medicine2015;15:40.">Buys 2015</a>; <a href="./references#CD011285-bbs2-0101" title="PandeyA , KhungerM , GargS , KumbhaniDJ , ChinKM , BerryJD . Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis. Circulation Heart Failure2015;8(6):1032-43.">Pandey 2015</a>; <a href="./references#CD011285-bbs2-0120" title="YanL , ShiW , LiuZ , ZhaoZ , LuoQ , ZhaoQ , et al. The benefit of exercise-based rehabilitation programs in patients with pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Pulmonary Circulation2021;11:20458940211007810. [DOI: 10.1177/20458940211007810]">Yan 2021</a>; <a href="./references#CD011285-bbs2-0121" title="YuanP , YuanXT , SunXY , PudasainiB , LiuJM , HuQH . Exercise training for pulmonary hypertension: a systematic review and meta-analysis. International Journal of Cardiology2015;178:142-6.">Yuan 2015</a>). One early systematic review, <a href="./references#CD011285-bbs2-0073" title="BuysR , AvilaA , CornelissenVA . Exercise training improves physical fitness in patients with pulmonary arterial hypertension: a systematic review and meta-analysis of controlled trials. BMC Pulmonary Medicine2015;15:40.">Buys 2015</a> examined only controlled trials up to December 2013, not all of which were randomised. They extracted five studies, three of which we included in our analyses (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>); however, we excluded the other two studies as participants were non‐randomly allocated to exercise or control groups (<a href="./references#CD011285-bbs2-0028" title="FoxBD , KassirerM , WeissI , RavivY , PeledN , ShitritD , et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. Journal of Cardiac Failure2011;17(3):196-200. ">Fox 2011</a>; <a href="./references#CD011285-bbs2-0095" title="Martinez-QuintanaE , Miranda-CalderinG , Ugarte-LopeteguiA , Rodriguez-GonzalezF . Rehabilitation program in adult congenital heart disease patients with pulmonary hypertension. Congenital Heart Disease2010;5(1):44-50.">Martinez‐Quintana 2010</a>). The results of this early systematic review of RCTs generated similar results as the current review with a large increase in 6MWD and VO<sub>2peak</sub> (6MWD: MD for exercise group 72.5 m, 95% CI 46.0 to 99.1; 5 studies; VO<sub>2peak</sub>: MD for exercise group 2.2 mL/kg/min, 95% CI 46.0 to 99.1; 3 studies). Other early systematic reviews included both RCTs and observational studies, and hence analysed a larger number of studies (<a href="./references#CD011285-bbs2-0071" title="BabuAS , PadmakumarR , MaiyaAG , MohapatraAK , KamathRL . Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials. Heart, Lung and Circulation2016;25(4):333-41.">Babu 2016a</a>; <a href="./references#CD011285-bbs2-0101" title="PandeyA , KhungerM , GargS , KumbhaniDJ , ChinKM , BerryJD . Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis. Circulation Heart Failure2015;8(6):1032-43.">Pandey 2015</a>; <a href="./references#CD011285-bbs2-0121" title="YuanP , YuanXT , SunXY , PudasainiB , LiuJM , HuQH . Exercise training for pulmonary hypertension: a systematic review and meta-analysis. International Journal of Cardiology2015;178:142-6.">Yuan 2015</a>). <a href="./references#CD011285-bbs2-0071" title="BabuAS , PadmakumarR , MaiyaAG , MohapatraAK , KamathRL . Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials. Heart, Lung and Circulation2016;25(4):333-41.">Babu 2016a</a> reported that exercise training resulted in large changes in exercise capacity, HRQoL and very few adverse events in 15 included studies, four of which were RCTs. <a href="./references#CD011285-bbs2-0121" title="YuanP , YuanXT , SunXY , PudasainiB , LiuJM , HuQH . Exercise training for pulmonary hypertension: a systematic review and meta-analysis. International Journal of Cardiology2015;178:142-6.">Yuan 2015</a> undertook a meta‐analysis and reported large increases in exercise capacity (6MWD and peak exercise capacity), HRQoL (measured using the SF‐36) and few adverse events in the 12 studies they classified as being either randomised (two studies), observational‐control (four studies) or observational (six studies). The authors undertook a subgroup analysis of RCTs and whilst, producing similar results to our study for exercise capacity (MD for exercise group 62 m, 95% CI 45.6 to 78.8), these authors included data from <a href="./references#CD011285-bbs2-0117" title="WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84.">Weinstein 2013</a>, which we considered to be a duplicate report of one of the studies included in our review (<a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a>). </p> <p>More‐recent systematic reviews of exercise‐based rehabilitation also reported substantial improvements in exercise capacity. <a href="./references#CD011285-bbs2-0069" title="AlbanaqiAL , RahimiGR , SmartNA . Exercise training for pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Biological Research for Nursing2021;12:2691-705.">Albanaqi 2021</a> (nine studies, data extracted up to June 2020) and <a href="./references#CD011285-bbs2-0120" title="YanL , ShiW , LiuZ , ZhaoZ , LuoQ , ZhaoQ , et al. The benefit of exercise-based rehabilitation programs in patients with pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Pulmonary Circulation2021;11:20458940211007810. [DOI: 10.1177/20458940211007810]">Yan 2021</a> (eight studies, data extracted up to January 2021) both reported similar increases in 6MWD as our review for the exercise group (<a href="./references#CD011285-bbs2-0069" title="AlbanaqiAL , RahimiGR , SmartNA . Exercise training for pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Biological Research for Nursing2021;12:2691-705.">Albanaqi 2021</a>: MD 47.7 m, 95% CI 32.4 to 61.0; 10 studies; <a href="./references#CD011285-bbs2-0120" title="YanL , ShiW , LiuZ , ZhaoZ , LuoQ , ZhaoQ , et al. The benefit of exercise-based rehabilitation programs in patients with pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Pulmonary Circulation2021;11:20458940211007810. [DOI: 10.1177/20458940211007810]">Yan 2021</a>: MD 47.8 m, 95% CI 33.9 to 61.7; 8 studies). <a href="./references#CD011285-bbs2-0069" title="AlbanaqiAL , RahimiGR , SmartNA . Exercise training for pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials. Biological Research for Nursing2021;12:2691-705.">Albanaqi 2021</a> also reported similar changes in VO<sub>2peak</sub> to our review (MD 2.79 mL/kg/min, 95% CI 2.00 to 3.59). Notably these reviews included RCTs that examined solely inspiratory muscle training, which we did not consider for our review (<a href="./references#CD011285-bbs2-0016" title="AslanGK , AkıncıB , YeldanI , OkumusG . A randomized controlled trial on inspiratory muscle training in pulmonary hypertension: effects on respiratory functions, functional exercise capacity, physical activity, and quality of life. Heart and Lung2020;49:381-7. AslanGK , AkinciB , YeldanI , DeveliEU , OkumusG . Inspiratory muscle training in patients with pulmonary hypertension: pilot study. European Respiratory Journal2017;50(Suppl 61):PA3455. NCT03385733. Inspiratory muscle training in pulmonary hypertension [The effects of inspiratory muscle training on exercise capacity, physical activity and quality of life in pulmonary hypertension]. clinicaltrials.gov/ct2/show/NCT03385733 (first received 28 December 2017). ">Aslan 2020</a>; <a href="./references#CD011285-bbs2-0054" title="TranD , MunozP , LauE , AlisonJ , BrownM , ZhengY , et al. Inspiratory muscle training improves six-minute walk distance in adults with pulmonary arterial hypertension . Journal of the American College of Cardiology2020;75(11):2085. TranD , MunozP , LauEM , AlisonJA , BrownM , ZhengY , et al. Inspiratory muscle training improves inspiratory muscle strength and functional exercise capacity in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a pilot randomised controlled study. Heart, Lung and Circulation2021;30(3):388-95. ">Tran 2020</a>). Moreover, neither of these reviews included the more recently published RCTs of exercise‐based rehabilitation that we included (<a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a>; <a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a>; <a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a>; <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>). Studies that included both inpatient and supervised home‐based exercise were included in the previous (<a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a>; <a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a>; <a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a>) and current review (<a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a>; <a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). It is worth noting that <a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a>, which consisted of supervised home‐based exercise training, was included in the current review given the high level of home supervision and the structure of the exercise‐based rehabilitation programme. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011285-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram." data-id="CD011285-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011285-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011285-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Figure 4. Funnel plot comparison: exercise intervention versus usual care for change in six‐minute walk distance following exercise‐based rehabilitation." data-id="CD011285-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Figure 4. Funnel plot comparison: exercise intervention versus usual care for change in six‐minute walk distance following exercise‐based rehabilitation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 1: Exercise capacity: 6‐minute walk distance (6MWD)" data-id="CD011285-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 1: Exercise capacity: 6‐minute walk distance (6MWD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 2: Exercise capacity: 6MWD inpatient vs outpatient studies" data-id="CD011285-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 2: Exercise capacity: 6MWD inpatient vs outpatient studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 3: Exercise capacity: peak exercise capacity (VO 2peak)" data-id="CD011285-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 3: Exercise capacity: peak exercise capacity (VO <sub>2peak</sub>) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 4: Exercise capacity: VO 2peak, inpatient vs outpatient studies" data-id="CD011285-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 4: Exercise capacity: VO <sub>2peak</sub>, inpatient vs outpatient studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 5: Exercise capacity: peak power" data-id="CD011285-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 5: Exercise capacity: peak power</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 6: Exercise capacity: peak power, inpatient vs outpatient studies" data-id="CD011285-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 6: Exercise capacity: peak power, inpatient vs outpatient studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 7: Exercise capacity: anaerobic threshold" data-id="CD011285-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 7: Exercise capacity: anaerobic threshold</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 8: Serious adverse events" data-id="CD011285-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 8: Serious adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 9: Health‐related quality of life (HRQoL) 36‐item Short Form (SF‐36): Physical Component Summary" data-id="CD011285-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 9: Health‐related quality of life (HRQoL) 36‐item Short Form (SF‐36): Physical Component Summary </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 10: HRQoL SF‐36: Mental Component Summary" data-id="CD011285-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 10: HRQoL SF‐36: Mental Component Summary</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 11: HRQoL SF‐36: Physical Function" data-id="CD011285-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 11: HRQoL SF‐36: Physical Function</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 12: HRQoL SF‐36: Role Physical" data-id="CD011285-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 12: HRQoL SF‐36: Role Physical</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 13: HRQoL SF‐36: Bodily Pain" data-id="CD011285-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 13: HRQoL SF‐36: Bodily Pain</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 14: HRQoL SF‐36: General Health" data-id="CD011285-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 14: HRQoL SF‐36: General Health</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 15: HRQoL SF‐36: Mental Health" data-id="CD011285-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 15: HRQoL SF‐36: Mental Health</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 16: HRQoL SF‐36: Role Emotional" data-id="CD011285-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 16: HRQoL SF‐36: Role Emotional</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 17: HRQoL SF‐36: Vitality" data-id="CD011285-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 17: HRQoL SF‐36: Vitality</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 18: HRQoL SF‐36: Social Function" data-id="CD011285-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 18: HRQoL SF‐36: Social Function</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 19: HRQoL: CAMPHOR Activities" data-id="CD011285-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 19: HRQoL: CAMPHOR Activities</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 20: HRQoL: CAMPHOR Symptoms" data-id="CD011285-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 20: HRQoL: CAMPHOR Symptoms</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 21: HRQoL: CAMPHOR Quality of Life" data-id="CD011285-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 21: HRQoL: CAMPHOR Quality of Life</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 22: Cardiopulmonary haemodynamics" data-id="CD011285-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 22: Cardiopulmonary haemodynamics</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 23: Functional Class" data-id="CD011285-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 23: Functional Class</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 24: B‐type natriuretic peptide" data-id="CD011285-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 24: B‐type natriuretic peptide</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 25: Exercise capacity: 6MWD, sensitivity analysis" data-id="CD011285-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 25: Exercise capacity: 6MWD, sensitivity analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 26: Exercise capacity: VO 2peak, sensitivity analysis" data-id="CD011285-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 26: Exercise capacity: VO <sub>2peak</sub>, sensitivity analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 27: Exercise capacity: peak power, sensitivity analysis" data-id="CD011285-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 27: Exercise capacity: peak power, sensitivity analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 28: HRQoL SF‐36: Physical Component Score sensitivity analysis" data-id="CD011285-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 28: HRQoL SF‐36: Physical Component Score sensitivity analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011285-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/urn:x-wiley:14651858:media:CD011285:CD011285-CMP-001.29" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Exercise versus control, Outcome 29: HRQoL SF‐36: Mental Component Score sensitivity analysis" data-id="CD011285-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.29.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_t/tCD011285-CMP-001.29.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1: Exercise versus control, Outcome 29: HRQoL SF‐36: Mental Component Score sensitivity analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/media/CDSR/CD011285/image_n/nCD011285-CMP-001.29.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011285-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Exercise compared to control for pulmonary hypertension</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Exercise compared to control for pulmonary hypertension</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with pulmonary hypertension </p> <p><b>Settings:</b> inpatient or outpatient rehabilitation, or both </p> <p><b>Intervention:</b> exercise training </p> <p><b>Comparison:</b> control: people who had usual care and did not undertake exercise training programme </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Exercise</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity: 6MWD</b><br/>Distance, metres<br/>Follow‐up median 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in 6MWD ranged from −29 m to 16.9 m</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in 6MWD in the intervention groups was <b>48.52 m higher</b> (33.42 to 63.62 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>418<br/>(11 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may result in a large increase in 6MWD.</p> <p>PAH subgroup (3 studies, 71 participants): mean 6MWD for intervention group was <b>63.97 m</b> higher (95% CI 8.74 to 119.21 higher; P = 0.02, I² = 75%). </p> <p>Mixed PH subgroup (8 studies, 347 participants): mean 6MWD for intervention group was <b>44.16 m</b> higher (95% CI 28.97 to 59.36 higher; P &lt; 0.001, I² = 72%). </p> <p>Examining heterogeneity, inpatient vs outpatient exercise training: included inpatient exercise training (5 studies, 280 participants): mean 6MWD for intervention group was <b>50.54 m</b> higher (95% CI 39.00 to 62.07 higher; P &lt; 0.001, I² = 81%). Outpatient exercise training (6 studies, 138 participants): mean 6MWD for intervention group was <b>36.69 m</b> higher (95% CI 27.85 to 45.52 higher; P &lt; 0.001, I² = 53%). </p> <p>Minimal important difference was 30 m.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity: VO<sub>2peak</sub> </b> </p> <p>Oxygen uptake, mL/kg/min<br/>Follow‐up median 13.5 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in VO<sub>2peak</sub> ranged from −0.5 mL/kg/min to 0.4 mL/kg/min </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean VO<sub>2peak</sub> in the intervention groups was <b>2.07 mL/kg/min higher</b><br/>(1.57 to 2.57 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>314<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may increase peak oxygen uptake.</p> <p>PAH subgroup (2 studies, 36 participants): mean VO<sub>2peak</sub> in the intervention groups was <b>1.28 mL/kg/min higher</b> (95% CI 0.19 lower to 2.75 higher; P = 0.09, I² = 0%). </p> <p>Mixed PH subgroup (5 studies, 278 participants): mean VO<sub>2peak</sub> in the intervention groups was <b>2.17 mL/kg/min higher</b> (95% CI 1.64 to 2.70 higher, P &lt; 0.001, I² = 72%). </p> <p>Examining heterogeneity, inpatient vs outpatient exercise training: included inpatient exercise training (3 studies, 217 participants): mean VO<sub>2peak</sub> for intervention group was <b>2.00</b> <b>mL/kg/min higher</b> (95% CI 1.36 to 2.64 higher, P &lt; 0.001, I² = 83%). Outpatient exercise training (4 studies, 97 participants): mean VO<sub>2peak</sub> for intervention group was <b>2.18 mL/kg/min higher</b> (95% CI 1.38 to 2.98 higher, P &lt; 0.001, I² = 21%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Exercise capacity: peak power</b> </p> <p>watts<br/>Follow‐up median 13.5 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in W<sub>peak</sub> ranged from −4 W to 10 W </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean exercise capacity: peak power in the intervention groups was <b>9.69 W higher</b><br/>(5.52 to 13.85 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may increase peak power.</p> <p>PAH subgroup (2 studies, 36 participants): mean peak power in the intervention groups was <b>14.24 W higher</b> (95% CI 5.78 to 22.70 higher; P &lt; 0.001, I² = 0%). </p> <p>Mixed PH subgroup (3 studies, 190 participants): mean W<sub>peak</sub> in the intervention groups was <b>8.22 W higher</b> (95% CI 3.43 to 13.01 higher; P &lt; 0.001, I² = 84%). </p> <p>Examining heterogeneity, inpatient vs outpatient exercise training: included inpatient exercise training (3 studies, 190 participants): mean peak power in the intervention groups was <b>8.22 W higher</b> (95% CI 3.43 to 13.01 higher; P = 0.008, I² = 84%). Outpatient exercise training only (2 studies, 36 participants): mean peak power in the intervention groups was <b>14.24 W higher</b> (95% CI 5.78 to 22.70 higher; P &lt; 0.001, I² = 0%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> <p>Follow‐up median 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 total for control group</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RD 0 (–0.03 to<br/>0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>439 (11 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training is probably not associated with an increased risk of a serious adverse event. </p> <p>PAH subgroup (3 studies, 109 participants): RD –0.01 (95% CI –0.07 to 0.06). 1 death reported in the control group (<a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a>). Mixed PH subgroup (8 studies, 330 participants): RD 0.01 (95% CI –0.03 to 0.04). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQoL SF‐36: PCS</b> </p> <p>units</p> <p>Follow‐up median 11 weeks. Note higher scores = better health status</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the PCS ranged from ‐1 to 3.9 points</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean HRQoL SF‐36: PCS in the intervention groups was <b>3.98 points higher</b> (1.89 to 6.07 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training likely improves the physical components of HRQoL.</p> <p>PAH subgroup (2 studies, 33 participants): mean HRQoL SF‐36: PCS in the intervention groups was <b>4.63 higher</b> (95% CI 0.80 to 8.47 higher). </p> <p>Mixed PH subgroup (3 studies, 33 participants): mean HRQoL SF‐36: PCS in the intervention groups was <b>3.71 higher</b> (95% CI 1.20 to 6.19 higher). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HRQoL SF‐36: MCS</b> </p> <p>units</p> <p>Follow‐up median 11 weeks. Note higher scores = better health status</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the MCS ranged from −3.1 to 2.3 points.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean HRQoL SF‐36: MCS in the intervention groups was <b>3.60 points higher</b> (1.21 to 5.98 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>186<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training likely improves the mental components of HRQoL.</p> <p>PAH subgroup (2 studies, 33 participants): mean HRQoL SF‐36: MCS in the intervention groups was <b>4.17 points higher</b> (95% CI 0.01 to 8.34 higher). </p> <p>Mixed PH subgroup (3 studies, 153 participants): mean HRQoL SF‐36: MCS in the intervention groups was <b>3.31 points higher</b> (95% CI 0.40 to 6.22 higher). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiopulmonary haemodynamics (mPAP)</b> </p> <p>mmHg</p> <p>Follow‐up median 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the mPAP ranged from 5 to 5.8 mmHg.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mPAP in the exercise group was <b>9.29 mmHg lower</b> (12.96 to 5.61 mmHg lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>133 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise training may result in a large decrease in mPAP.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the response on control is the median control group response across studies. </p> <p><b>6MWD:</b> 6‐minute walk distance; <b>CI:</b> confidence interval; <b>HRQoL:</b> health‐related quality of life; <b>MCS:</b> Mental Component Summary; <b>MD:</b> mean difference; <b>mPAP:</b> mean pulmonary arterial pressure; <b>PAH:</b> pulmonary arterial hypertension; <b>PCS:</b> Physical Component Summary; <b>PH:</b> pulmonary hypertension; <b>RD:</b> risk difference; <b>SF‐36:</b> 36‐item Short Form; <b>VO<sub>2peak</sub>:</b> peak oxygen capacity; <b>W:</b> watts. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Five of 11 studies reported incomplete outcome data. Downgraded one level.<br/><sup>b</sup> Inconsistency: I² &gt; 60%. Downgraded one level.<br/><sup>c</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Three of seven studies reported incomplete outcome data. Downgraded one level.<br/><sup>d</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Three of five studies reported incomplete outcome data. Downgraded one level.<br/><sup>e</sup> No studies reported allocation concealment or blinding of participants or personal to intervention (performance bias). Downgraded one level.<br/><sup>f</sup> Both studies had high risk of performance bias (participants and personnel not blinded), high risk of attrition bias and high risk of reporting bias. Downgraded two levels. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Exercise compared to control for pulmonary hypertension</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011285-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study characteristics</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study design (grouping)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant age (years), gender</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Pulmonary arterial pressure (mmHg)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Duration of programme</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Delivery mode: inpatient/ outpatient/ home</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Exercise modality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Training dose (frequency/duration)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Training intensity</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome measures</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Funding sources</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0001" title="AtefH , AbdeenH . Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep and Breathing2021;25(4):1953-60. [DOI: 10.1007/s11325-020-02286-9]NCT04337671. Impact of aerobic training on sleep quality and aerobic fitness in male patients with pulmonary artery hypertension. clinicaltrials.gov/show/NCT04337671 (first received 8 April 2020). ">Atef 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 15 (1 withdrawal)</p> <p>Control: 15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 48 (SD 7)</p> <p>Control: 47 (SD 8)</p> <p>Gender: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP: unclear</p> <p>PASP:</p> <p>Exercise: 58 (SD 15)</p> <p>Control: 58 (SD 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0017"> <li> <p>Aerobic exercise (cycle ergometer)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 15–30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 min at lower workload (e.g. 20 W) and 1 min at higher workload (e.g. 35 W).</p> <p>60–70% of heart rate reserve; 60–70% of VO<sub>2</sub> max </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0018"> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>PASP</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cairo University</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0002" title="ButāneL , ŠablinskisM , SkrideA , ŠmiteD . Individually tailored 12-week home-based exercise program improves both physical capacity and sleep quality inpatients with pulmonary arterial hypertension. Medicina (Kaunas)2021;58(5):662. [DOI: 10.3390/medicina58050662]">Butane 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 10 (1 withdrawal)</p> <p>Control: 9 (2 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 61.6 (SD 18.5)</p> <p>Control: 68.3 (SD 16.6)</p> <p>Gender: (male/female)</p> <p>Exercise: 1/8</p> <p>Control: 0/7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 44.1 (SD 15.7)</p> <p>Control: 49.1 (SD 14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Home.</p> <p>Training supervised at the centre in weeks 1, 4 and 12; home‐based training with weekly telephone consultation for the remainder </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0019"> <li> <p>Aerobic exercise (walking, cycle ergometer)</p> </li> <li> <p>Strength exercise</p> </li> <li> <p>Inspiratory muscle training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p> <ul id="CD011285-list-0020"> <li> <p>Aerobic exercise: 3 times/week</p> </li> <li> <p>Strength exercise: 2 times/week</p> </li> <li> <p>Inspiratory muscle training: 5 times/week</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0021"> <li> <p>Aerobic exercise: 20–40 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0022"> <li> <p>Aerobic exercise: 5–6 on Borg scale; sustained SpO<sub>2</sub> or decrease of &lt; 5% from the baseline value. Progression was based on individual tolerability and provided by an increase in training duration and limited by 'alarm signs' (i.e. peak heart rate: &gt; 120 bpm; maximal decrease in SpO<sub>2</sub> of 85%; perceived exertion &gt; 6 and subjective symptoms of exercise intolerance) </p> </li> <li> <p>Strength exercise: 5–10 reps each set using bodyweight or low weights (0.5–1 kg)</p> </li> <li> <p>Inspiratory muscle training: 3 × 3 to 3 × 7 reps each set; 30–70% from max resistance</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0023"> <li> <p>6MWD</p> </li> <li> <p>Sleep Quality: Pittsburgh Sleep Quality Index</p> </li> <li> <p>HADS</p> </li> <li> <p>Inspiratory Pressure Test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0003" title="ChanL , ChinLM , KennedyM , WoolstenhulmeJG , NathanSD , WeinsteinAA , et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest2013;143(2):333-43. [DOI: 10.1378/chest.12-0993]ChanL , KennedyM , WoolstenhulmeJ , ConnorsG , NathanS , WeirN , et al. Improved six-minute walk distance and cardiorespiratory fitness in patients with pulmonary arterial hypertension following an intensive exercise program. Chest2011;140(4):854A. NCT00678821. Aerobic exercise in patients with pulmonary hypertension [Response and adaptation to aerobic exercise in patients with pulmonary hypertension: initial studies for establishing guidelines]. clinicaltrials.gov/show/NCT00678821 (first received 16 May 2008). WeinsteinAA , ChinLM , KeyserRE , KennedyM , NathanSD , WoolstenhulmeJG , et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine2013;107(5):778-84. [DOI: 10.1016/j.rmed.2013.02.006]WoolstenhulmeJG , GuccioneAA , HerrickJE , CollinsJP , NathanSD , ChanL , et al. Left ventricular function before and after aerobic exercise training in women with pulmonary arterial hypertension. Journal of Cardiopulmonary Rehabilitation and Prevention2019;39(2):118-26. [DOI: 10.1097/HCR.0000000000000397]">Chan 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 10</p> <p>Control: 13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 53 (SD 13)</p> <p>Control: 55.5 (SD 8.5)</p> <p>Gender: (male/female)</p> <p>Exercise: 0/10</p> <p>Control: 0/13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 40.3 (SD 13.8)</p> <p>Control: 43.8 (SD 14.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0024"> <li> <p>Aerobic exercise (treadmill walking)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>2–3 times/week</p> <p>Training duration: 30–45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70–80% of heart rate reserve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0025"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> <li> <p>HRQoL (CAMPHOR): Symptoms</p> </li> <li> <p>HRQoL (CAMPHOR): Activities</p> </li> <li> <p>HRQoL (CAMPHOR): QoL</p> </li> <li> <p>NYHA Class</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US National Institutes of Health</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0004" title="BenjaminN , KloseH , LichtblaufM , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – a prospective, randomized, controlled trial. European Respiratory Journal2016;48(Suppl 60):OA267. EhlkenN , LichtblauM , KloseH , WeidenhammerJ , FischerC , NechwatalR , et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. European Heart Journal2015;37(1):35-44. NagelC , BenjaminN , EgenlaufB , EichstaedtCA , FischerC , PalevičiūtėE , et al. Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration2021;100:369-78. ">Ehlken 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 46</p> <p>Control: 41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 55 (SD 15)</p> <p>Control: 57 (SD 15)</p> <p>Gender: (male/female)</p> <p>Exercise: 20/26</p> <p>Control: 20/21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 41 (SD 11.7)</p> <p>Control: 37.6 (SD 11.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient (3 weeks)</p> <p>Outpatient (unsupervised; performed at home; 12 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0026"> <li> <p>Aerobic exercise (interval bicycle ergometer, walking)</p> </li> <li> <p>Resistance exercise</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>Inpatient:</p> <p> <ul id="CD011285-list-0027"> <li> <p>Aerobic exercise: walking and cycling: 7 days/week</p> </li> <li> <p>Resistance exercise: 5 days/week</p> </li> <li> <p>Respiratory exercise: 5 days/week</p> </li> </ul> </p> <p>Outpatient (performed at home):</p> <p> <ul id="CD011285-list-0028"> <li> <p>Aerobic exercise: cycling: 5 times/week; walking: twice/week</p> </li> <li> <p>Resistance exercise: second daily</p> </li> <li> <p>Respiratory training: second daily</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0029"> <li> <p>Aerobic exercise: cycle ergometer: 10–25 min; walking: 60 min</p> </li> <li> <p>Resistance exercise: 30 min</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60–80% of heart rate reserve</p> <p>Heart rate maintained at &lt; 120 bpm; oxygen saturation maintained at &gt; 85%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0030"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>W<sub>peak</sub> </p> </li> <li> <p>Morbidity – adverse events</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Precluded from training</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>Discontinued training</p> </li> <li> <p>mPAP (mmHg)</p> </li> <li> <p>PVR (dynes)</p> </li> <li> <p>Cardiac output (L/min)</p> </li> <li> <p>NT‐proBNP</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Centre for Pulmonary Hypertension, Thorax clinic at the University of Heidelberg, Germany </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0005" title="ErtanO , AslanGK , AkinciB , BilgeAK , InancM , OkumusG . Effect of ground-based walk training in pulmonary hypertension. American Journal of Cardiology2022;174:172-8. ErtanO , AslanGK , AkinciB , OkumusG . Effects of ground-based walking training in pulmonary hypertension. European Respiratory Journal2020;56((Suppl 64)):4743. NCT03762577. Effects of ground-based walking training in pulmonary hypertension [A randomized controlled trial of ground-based walking training for adult patients with pulmonary hypertension]. clinicaltrials.gov/show/nct03762577 (first received 3 December 2018). ">Ertan 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 15 (3 withdrawals)</p> <p>Control: 12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 49.6 (SD 9.9)</p> <p>Control: 44.3 (SD 9.4)</p> <p>Gender: (male/female)</p> <p>Exercise: 2/10</p> <p>Control: 3/9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP:</p> <p>Exercise: 47.2 (SD 18.8)</p> <p>Control: 40.5 (SD 18.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient twice/week</p> <p>Home (unsupervised) once/week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0031"> <li> <p>Ground‐based walking training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: ≥ 3 times/week (2 days at hospital and ≥ 1 at home)</p> <p>Training duration: initially 30 min; then increased by 5 min once every 2 weeks to a max of 45 min after 8 weeks depending on exercise tolerance </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical symptom scores were used to determine</p> <p>exercise intensity</p> <p>Heart rate maintained at 120 bpm; perceived exertion level at 3–4 on modified Borg scale </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0032"> <li> <p>Endurance Shuttle Walk Test</p> </li> <li> <p>Incremental Shuttle Walk Test</p> </li> <li> <p>6MWD</p> </li> <li> <p>HRQoL (EmPHasis‐10)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Istanbul University – Cerrahpasa Scientific Research Projects Unit</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0006" title="GandertonL , GainK , FowlerR , LuntD , WinshipP , BostockS , et al. Effects of exercise training on exercise capacity and quality of life in pulmonary arterial hypertension. Respirology2013;18(Suppl 2):74 (P146). GandertonL , JenkinsS , GainK , FowlerR , WinshipP , LuntD , et al. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulmonary Medicine2011;11:25. [DOI: 10.1186/1471-2466-11-25]">Ganderton 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 5</p> <p>Control: 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 51 (range 40–53)</p> <p>Control: 53 (range 42–57)</p> <p>Gender: (male/female)</p> <p>Exercise: 0/5</p> <p>Control: 1/4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 23 (range 19–29)</p> <p>Control: 49 (range 20–65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient, supervised sessions.</p> <p>Commenced 1 home‐based unsupervised session/week in last 4 weeks of supervised programme; then asked to continue with home programme (unsupervised) for an additional 12 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0033"> <li> <p>Lower limb endurance training (walking and cycling)</p> </li> <li> <p>Lower limb functional strength training (step ups and sit to stands) Endurance training of the upper limbs </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60–70% of heart rate max (based on age predicted max, 220 – age); SpO<sub>2</sub> maintained at ≥ 92%; &lt; 4 on Borg scale </p> <p>Exercise intensity progressed based on the individual's response to training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0034"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>W<sub>peak</sub> </p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (CAMPHOR): Symptoms</p> </li> <li> <p>HRQoL (CAMPHOR): Activities</p> </li> <li> <p>HRQoL (CAMPHOR): QoL</p> </li> <li> <p>Morbidity</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Symptoms precluding training</p> </li> <li> <p>Discontinued training</p> </li> <li> <p>NYHA class</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Advanced Lung Disease Unit at Royal Perth Hospital and the Lung Institute of Western Australia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0007" title="González-SaizL , Fiuza-LucesC , Sanchis-GomarF , Santos-LozanoA , Quezada-LoaizaCA , Flox-CamachoA , et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. International Journal of Cardiology2017;15(231):277-83. NCT02288442. Exercise training (wholei+12) in pulmonary hypertension. clinicaltrials.gov/show/nct02288442 (first received 11 November 2014). Santos-LozanoAC , Fiuza-LucesD , Fernández-MorenoF , LlaveroJ , ArenasJA , LópezJ , et al. Exercise benefits in pulmonary hypertension. Journal of the American College of Cardiology2019;73:2906-7. ">González‐Saiz 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 20 (1 withdrawal)</p> <p>Control: 20 (4 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 46 (SD 11)</p> <p>Control: 45 (SD 12)</p> <p>Gender: (male/female)</p> <p>Exercise: 12/8</p> <p>Control: 12/8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 47 (SD 15)</p> <p>Control: 47 (SD 14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0035"> <li> <p>Aerobic training (cycling)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Inspiratory muscle training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p> <ul id="CD011285-list-0036"> <li> <p>Aerobic training: 5 times/week</p> </li> <li> <p>Resistance training: 3 times/week</p> </li> <li> <p>Inspiratory muscle training: twice daily, 6 days/week</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0037"> <li> <p>Aerobic training: 20–40 min</p> </li> <li> <p>Inspiratory muscle training: 5 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0038"> <li> <p>Aerobic training: Exercise‐rest intervals at a 1:1 ratio; 50% of the power output eliciting the anaerobic threshold during baseline assessment, with aim to reach 40 min (with about 15 min at the anaerobic threshold) during weeks 4–8 </p> </li> <li> <p>Resistance training: initial load of 6–8 in the 0–10 OMNI resistance exercise scale. The number of reps for each exercise was decreased with corresponding increases in load (kg) – 15 (weeks 1–2), 12 (weeks 3–4), 10 (weeks 5–6) and 8 reps (weeks 6–8) </p> </li> <li> <p>Inspiratory muscle training: 30 inspirations performed through a specific pressure‐load device against 40% of PI<sub>max</sub>, which was assessed each week to adjust the weekly load </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0039"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Adverse events</p> </li> <li> <p>HRQoL (SF‐36)</p> </li> <li> <p>NT‐proBNP</p> </li> <li> <p>5 Sit‐to‐Stand test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cátedra Real Madrid‐Universidad</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0008" title="GrünigE , MacKenzieA , PeacockAJ , EichstaedtCA , BenjaminN , NechwatalR , et al. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. European Heart Journal2020;14(23):2284-95. GrunigE , MacKenzieA , PeacockAJ , EichstaedtC , BenjaminN , NechwatalR , et al. Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension – results from a large European multicentre randomised controlled trial. European Respiratory Journal2020;56(Suppl 64):3972. NCT03345212. A randomized controlled multicenter trial of exercise training in pulmonary hypertension in European countries (EU-TRAIN-01) [Implementation and effect of exercise and respiratory training on 6-minute walking distance in patients with severe chronic pulmonary hypertension: a randomized controlled multicenter trial in European countries]. ClinicalTrials.gov/show/NCT03345212 (first received 17 November 2017). ">Grünig 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 68 (10 did not complete primary end point)</p> <p>Control: 61 (3 did not complete primary end point)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 52 (SD 12)</p> <p>Control: 55 (SD 13)</p> <p>Gender: (male/female)</p> <p>Exercise: 40/18</p> <p>Control: 45/13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 46.5 (SD 15.5) (n = 55)</p> <p>Control: 46.7 (SD 14.9) (n = 51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10–30 days (inpatient)</p> <p>11–12 weeks (home, unsupervised)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0040"> <li> <p>Aerobic training (cycle ergometer, guided walks)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Respiratory therapy</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>Inpatient: 5–7 days/week</p> <p>Home: 3–7 days/week</p> <p>Training duration:</p> <p> <ul id="CD011285-list-0041"> <li> <p>Cycle ergometer training: 10–25 min</p> </li> <li> <p>Guided walks: 60 min</p> </li> <li> <p>Resistance training: 30 min</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40–60% peak workload</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0042"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Wpeak</p> </li> <li> <p>WHO Functional Class</p> </li> <li> <p>NT‐proBNP</p> </li> <li> <p>SF‐36</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Echocardiography at rest and during exercise</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fondo Europeo de Desarrollo Regional (FEDER), EU</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0009" title="KagioglouO , MouratoglouSA , GiannakoulasG , KapoukranidouD , AnifantiM , DeligiannisA , et al. Long-term effect of an exercise training program on physical functioning and quality of life in pulmonary hypertension: a randomized controlled trial. Biomedical Research International2021;2021:8870615. [DOI: 10.1155/2021/8870615]">Kagioglou 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 16 (4 withdrawals)</p> <p>Control: 16 (6 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 54.7 (SD 15.6)</p> <p>Control: 53.1 (SD 12.1)</p> <p>Gender: (male/female)</p> <p>Exercise: 6/6</p> <p>Control: 3/7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 42.3 (SD 15.5)</p> <p>Control: 53.1 (SD 12.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0043"> <li> <p>Aerobic exercise (treadmill walking, cycling)</p> </li> <li> <p>Strengthening exercise</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 45–60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0044"> <li> <p>Aerobic exercise: 60–80% of the heart rate reached at peak oxygen uptake during initial exercise testing </p> </li> <li> <p>Strengthening exercise: 2 sets of 8–12 reps</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0045"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>VCO<sub>2</sub> </p> </li> <li> <p>V<sub>E</sub> </p> </li> <li> <p>V<sub>E</sub>/VCO<sub>2</sub> slope </p> </li> <li> <p>Resting blood pressure</p> </li> <li> <p>Resting heart rate</p> </li> <li> <p>Body surface area</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> <li> <p>State Trait Inventory</p> </li> <li> <p>Becks Depression Inventory</p> </li> <li> <p>Timed Up and Go Test</p> </li> <li> <p>Grip strength</p> </li> <li> <p>Lower limb strength</p> </li> <li> <p>Sit‐to‐Stand Test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0010" title="LeyS , FinkC , RisseF , EhlkenN , FischerC , Ley-ZaporozhanJ , et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. European Radiology2013;23(2):324-31. [DOI: 10.1007/s00330-012-2606-z]">Ley 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 10</p> <p>Control: 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 47 (SD 8)</p> <p>Control: 54 (SD 14)</p> <p>Gender: (male/female)</p> <p>Exercise: 2/8</p> <p>Control: 4/6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 48 (SD 19)</p> <p>Control: 50 (SD 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0046"> <li> <p>Aerobic training (cycle ergometer, walking)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p> <ul id="CD011285-list-0047"> <li> <p>Cycle ergometry: daily</p> </li> <li> <p>Walking: daily</p> </li> <li> <p>Resistance training: 5 times/week</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0048"> <li> <p>Cycle ergometry: 10–25 min/day</p> </li> <li> <p>Walking: 60 min/day</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0049"> <li> <p>Aerobic training: commence at 60–80% of heart rate reserve; progress as per individual tolerability and improvement </p> </li> <li> <p>Resistance training: light weights (0.5–1 kg)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0050"> <li> <p>Morbidity – adverse events</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Precluded from training</p> </li> <li> <p>6MWD</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German National Research Agency</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0011" title="EhlkenN , MerelesD , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training to improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. European Respiratory Journal2006;28(Suppl 50):372s (2220). MerelesD , EhlkenN , KreuscherS , GhofraniS , HoeperMM , HalankM , et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation2006;114(14):1482-9. [DOI: 10.1161/CIRCULATIONAHA.106.618397]">Mereles 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 15</p> <p>Control: 15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 47 (SD 12)</p> <p>Control: 53 (SD 14)</p> <p>Gender: (male/female)</p> <p>Exercise: 5/10</p> <p>Control: 5/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 49.5 (SD 17.6)</p> <p>Control: 49.6 (SD 12.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks (inpatient)</p> <p>12 weeks (outpatient)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inpatient/home (unsupervised)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0051"> <li> <p>Aerobic training (cycle ergometer, walking)</p> </li> <li> <p>Resistance training</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency:</p> <p>Inpatient:</p> <p> <ul id="CD011285-list-0052"> <li> <p>Cycle ergometer: 7 days/week</p> </li> <li> <p>Walking: 7 days/week</p> </li> <li> <p>Resistance training: 5 days/week</p> </li> <li> <p>Respiratory training: 5 days/week</p> </li> </ul> </p> <p>Outpatient:</p> <p> <ul id="CD011285-list-0053"> <li> <p>Cycle ergometer: 5 times/week</p> </li> <li> <p>Walking: twice/week</p> </li> <li> <p>Resistance training: second daily</p> </li> <li> <p>Respiratory training: second daily</p> </li> </ul> </p> <p>Training duration:</p> <p> <ul id="CD011285-list-0054"> <li> <p>Cycle ergometer: 10–25 min Walking: 60 min</p> </li> <li> <p>Resistance training: 30 min</p> </li> <li> <p>Respiratory training: 30 min</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0055"> <li> <p>Aerobic training: 60–80% of heart rate reserve; heart rate maintained at &lt; 120 bpm; oxygen saturation &gt; 85% </p> </li> <li> <p>Resistance training: low weights (0.5–1 kg)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0056"> <li> <p>6MWD</p> </li> <li> <p>VO<sub>2peak</sub> </p> </li> <li> <p>W<sub>peak</sub> </p> </li> <li> <p>Morbidity – adverse events</p> </li> <li> <p>Disease progression</p> </li> <li> <p>Precluded from training</p> </li> <li> <p>Anaerobic threshold</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL(SF‐36): Mental Component Summary Score</p> </li> <li> <p>HRQoL (CAMPHOR): QoL</p> </li> <li> <p>NYHA Functional Class</p> </li> <li> <p>Discontinued training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>German Pulmonary</p> <p>Hypertension Group, Pulmonale Hypertonie e.V., Rheinstetten, Germany</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0012" title="RakhmawatiA , AchmadIN , HartopoAB , AnggrahiniDW , ArsoIA , EmotoN , et al. Exercise program improves functional capacity and quality of life in uncorrected atrial septal defect-associated pulmonary arterial hypertension: a randomized-control pilot study. Annals of Rehabilitation Medicine2020;44(6):468-80. ">Rakhmawati 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 20 (1 withdrawal)</p> <p>Control: 19 (3 withdrawals)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 37.5 (SD 8.8)</p> <p>Control: 35.5 (SD 10.4)</p> <p>Gender: (male/female)</p> <p>Exercise: 1/19</p> <p>Control: 2/16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 61.4 (SD 14.2)</p> <p>Control: 56.8 (SD 11.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks (inpatient)</p> <p>10 weeks (outpatient)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient (supervised every 2 weeks), home (3 times/week, unsupervised)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0057"> <li> <p>Treadmill walking (inpatient)</p> </li> <li> <p>Walking on level ground (outpatient)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 3 times/week</p> <p>Training duration: 30 min (inpatient); continuous or 2 × 15 min or 3 × 10 min (outpatient)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60–70% of the max heart rate by age</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0058"> <li> <p>6MWD</p> </li> <li> <p>EQ‐5D‐3L (EuroQol)</p> </li> <li> <p>Utility Index</p> </li> <li> <p>NT‐proBNP</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Universitas Gadjah Mada,</p> <p>Jogjakarta, Indonesia</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0013" title="WilkinsonA , ElliotCA , CondliffeR , MawsonS , ArmstrongIJ , BillingsC , et al. A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary hypertension. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin, Germany. 2008. WilkinsonA , ElliotCA , MawsonS , ArmstrongI , BillingsC , KielyDG . A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. Thorax2007;62(Suppl iii):A16. ">Wilkinson 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 18</p> <p>Control: 18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age: unclear</p> <p>Gender: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP: unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outpatient/home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0059"> <li> <p>No specific details, exercise tailored to participant's needs</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single 1‐to‐1 class with a physiotherapist followed by home training using exercise prescription. Follow‐up telephone support was provided throughout the intervention period </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise tailored to participant's needs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0060"> <li> <p>Incremental Shuttle Walk Test</p> </li> <li> <p>Endurance Shuttle Walk Test</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Royal Hallamshire Hospital, Sheffield, UK</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011285-bbs2-0014" title="WojciukM , CiolkiewiczM , Kuryliszyn-MoskalA , Chwiesko-MinarowskaS , SawickaE , Ptaszynska-KopczynskaK , et al. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study. BMC Sports Science Medical Rehabilitation2021;13(1):79. ">Wojciuk 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCT (parallel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exercise: 23 (2 refused intervention, 4 lost to follow‐up, 1 excluded from</p> <p>analysis)</p> <p>Control: 23 (23 lost to follow‐up due to COVID‐19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Exercise: 48.9 (SD 18.3)</p> <p>Control: 53.7 (SD 12.8)</p> <p>Gender: (male/female)</p> <p>Exercise: 9/7</p> <p>Control: 10/13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mPAP</p> <p>Exercise: 47.2 (SD 14.9)</p> <p>Control: 49.1 (SD 14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0061"> <li> <p>Interval march training</p> </li> <li> <p>Respiratory training</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Training frequency: 5 days/week, once/day</p> <p>Training duration: March training: &gt; 30 min interrupted every 2 minutes by 1 of 5 respiratory exercises </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4–5 on modified Borg scale; 60–70% of heart rate reserve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD011285-list-0062"> <li> <p>6MWD</p> </li> <li> <p>PI<sub>max</sub> </p> </li> <li> <p>P<sub>Emax</sub> </p> </li> <li> <p>Grip strength</p> </li> <li> <p>HRQoL (SF‐36): Physical Functioning</p> </li> <li> <p>HRQoL (SF‐36): Role Physical</p> </li> <li> <p>HRQoL (SF‐36): Bodily Pain</p> </li> <li> <p>HRQoL (SF‐36): General Health</p> </li> <li> <p>HRQoL (SF‐36): Vitality</p> </li> <li> <p>HRQoL (SF‐36): Social Function</p> </li> <li> <p>HRQoL (SF‐36): Role Emotional</p> </li> <li> <p>HRQoL (SF‐36): Mental Health</p> </li> <li> <p>HRQoL (SF‐36): Physical Component Summary Score</p> </li> <li> <p>HRQoL (SF‐36): Mental Component Summary Score</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Medical University of Bialystok, Bialystok, Poland</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="12"> <div class="table-footnote"> <p>6MWD: six‐minute walk distance; bpm: beats per minute; EQ‐5D‐3L: European Quality of Life 5 Dimensions 3 Level Version; HADS: Hospital Anxiety Depression Scale; HRQoL: health‐related quality of life; max: maximum; min: minute; mPAP: mean pulmonary arterial pressure; n: number; NT‐proBNP: N‐terminal pro‐brain natriuretic peptide; NYHA: New York Heart Association; PASP: pulmonary arterial systolic pressure; P<sub>Emax</sub>: maximal expiratory pressure; PI<sub>max</sub>: maximal inspiratory pressure; PVR: pulmonary vascular resistance; QoL: quality of life; RCT: randomised controlled trial; rep: repetition; SD: standard deviation; SpO<sub>2</sub>: oxygen saturation; V<sub>E</sub>: pulmonary ventilation; VCO<sub>2</sub>: carbon dioxide production; VO<sub>2peak</sub>: peak oxygen capacity; W<sub>peak</sub>: peak workload; WHO: World Health Organization. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/full#CD011285-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011285-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Exercise versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Exercise capacity: 6‐minute walk distance (6MWD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>48.52 [33.42, 63.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Pulmonary arterial hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>63.97 [8.74, 119.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Mixed pulmonary hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>347</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>44.16 [28.97, 59.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Exercise capacity: 6MWD inpatient vs outpatient studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>48.29 [33.32, 63.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Inpatient exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>59.39 [29.95, 88.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Outpatient exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>43.21 [23.84, 62.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Exercise capacity: peak exercise capacity (VO <sub>2peak</sub>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [1.57, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Mixed pulmonary hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [1.64, 2.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Pulmonary arterial hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [‐0.21, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Exercise capacity: VO <sub>2peak</sub>, inpatient vs outpatient studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [1.57, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Inpatient exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [1.36, 2.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Outpatient exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [1.38, 2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Exercise capacity: peak power <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.69 [5.52, 13.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Mixed pulmonary hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.22 [3.43, 13.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Pulmonary arterial hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.24 [5.78, 22.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Exercise capacity: peak power, inpatient vs outpatient studies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.69 [5.52, 13.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Inpatient exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.22 [3.43, 13.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Outpatient exercise training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.24 [5.78, 22.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Exercise capacity: anaerobic threshold <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.53, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Mixed pulmonary hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Pulmonary arterial hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.07, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Health‐related quality of life (HRQoL) 36‐item Short Form (SF‐36): Physical Component Summary <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.98 [1.89, 6.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Mixed pulmonary hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.71 [1.22, 6.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Pulmonary arterial hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.63 [0.80, 8.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 HRQoL SF‐36: Mental Component Summary <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.60 [1.21, 5.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Mixed pulmonary hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.31 [0.40, 6.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Pulmonary arterial hypertension subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.17 [0.01, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 HRQoL SF‐36: Physical Function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.29 [‐1.15, 11.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 HRQoL SF‐36: Role Physical <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.46 [13.77, 27.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 HRQoL SF‐36: Bodily Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.17 [‐2.01, 10.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 HRQoL SF‐36: General Health <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [‐4.45, 8.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 HRQoL SF‐36: Mental Health <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.95 [2.12, 11.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 HRQoL SF‐36: Role Emotional <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.16 [‐4.98, 11.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 HRQoL SF‐36: Vitality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.67 [2.61, 16.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 HRQoL SF‐36: Social Function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.20 [7.32, 17.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 HRQoL: CAMPHOR Activities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐3.56, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 HRQoL: CAMPHOR Symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.08 [‐7.78, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 HRQoL: CAMPHOR Quality of Life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.42 [‐8.03, ‐2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Cardiopulmonary haemodynamics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.29 [‐12.96, ‐5.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 Functional Class <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.64, ‐0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 B‐type natriuretic peptide <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐68.69 [‐154.89, 17.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 Exercise capacity: 6MWD, sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>59.56 [37.64, 81.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.26 Exercise capacity: VO <sub>2peak</sub>, sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.27 [1.53, 3.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.27 Exercise capacity: peak power, sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.27 [8.57, 21.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.28 HRQoL SF‐36: Physical Component Score sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.1 All participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.61 [1.17, 8.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.29 HRQoL SF‐36: Mental Component Score sensitivity analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.1 All participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.33 [1.41, 7.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Exercise versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011285.pub3/references#CD011285-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011285.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011285-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011285-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011285-note-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011285-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011285-note-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="hu#CD011285-note-0014">Magyar</a> </li> <li class="section-language"> <a class="" href="id#CD011285-note-0020">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD011285-note-0018">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD011285-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD011285-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011285-note-0021">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD011285-note-0010">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD011285-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD011285-note-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011285-note-0016">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011285\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011285\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011285\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011285\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011285\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tlnpj831&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011285.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011285.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011285.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011285.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011285.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727061783"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011285.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727061787"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011285.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea2d4e9fcf401',t:'MTc0MDcyNzA2Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 